TempI

Aus coViki
Wechseln zu: Navigation, Suche




C7723464 2020. Contributory role of SARS-CoV-2 genomic variations and life expectancy in COVID-19 transmission and low fatality rate in Africa.
C7709652 2020. COVID-19 natural herd immunity and risk of neuropsychiatric disorders.
C7709602 ?. Syndrome inflammatoire avec atteinte multisystémique post-infection par le SARS-CoV-2 chez l?enfant : quand l?envisager et comment le prendre en charge ?
C7685301 ?. Role of gut-lung microbiome crosstalk in COVID-19.
C7670013 2020. SARS-CoV-2 und das Kawasaki-Syndrom.
33333024 ?. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
C7688432 ?. A Dermatologic Perspective on Multisystem Inflammatory Syndrome in Children.
C7604155 ?. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children.
33312565 2020. Rapid detection of SARS?CoV?2?specific memory T?cell immunity in recovered COVID?19 cases.
C7665476 ?. Conservation analysis of SARS-CoV-2 spike suggests complicated viral adaptation history from bat to human.
33312178 2020. MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity.
C7720652 ?. Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India.
C7692877 ?. Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh.
33319124 2021. Mutational insights into the envelope protein of SARS-CoV-2.
C7604183 2020. SÍNDROME HEMOFAGOCÍTICA EM CORONAVÍRUS 19: EXPERIÊNCIA DE UM CENTRO DE CURITIBA-PR.
C7604150 2020. IMUNOPATOLOGIA DA INFECÇÃO POR SARS-COV-2 EM PACIENTES ONCO-HEMATOLÓGICOS.
C7604096 2020. RELATO DE CASO: SINDROME HIPERINFLAMATÓRIA MULTISSISTÊMICA COVID 19 EM PACIENTE PORTADORA DE SÍNDROME MIELODISPLÁSICA- CITOPENIA REFRATÁRIA E ESPECTRO AUTISTA.
C7604066 2020. COVID-19 E SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA SEMELHANTE À DOENÇA DE KAWASAKI: REVISÃO SISTEMÁTICA.
C7604036 2020. SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA KAWASAKI-LIKE ASSOCIADA A COVID-19.
C7604054 2020. SÍNDROME HEMOFAGOCÍTICA EM PACIENTE COM LMA RECIDIVADA E COVID-19: RELATO DE CASO.
C7604043 2020. AVALIAÇÃO DAS SUBPOPULAÇÕES LINFOCITÁRIAS T B E NK EM PACIENTES COM COVID-19 GRAVE ATENDIDOS EM UM HOSPITAL UNIVERSITÁRIO.
33326767 2020. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
33310664 2021. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients.
33319167 ?. Structural characterization of Nonstructural protein 1 from SARS-CoV-2.
33319166 2021. Transcriptional response modules characterize IL-1? and IL-6 activity in COVID-19.
C7698825 ?. Development of Herd Immunity to COVID-19 in Louisiana nursing homes.
33328133 ?. Kawasaki disease and COVID-19; a pretext for a hot topic.
C7711743 ?. Potential implications of SARS-CoV-2 oral infection in the host microbiota.
33316043 ?. A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages.
C7677618 ?. Physiochemical Characterization and Domain Annotation of ORF1ab Polyprotein of Novel Corona Virus 19.
C7677617 ?. Comparing Proteomics of NCoV 19 and MERS Corona Virus.
C7677611 ?. Genomics and Evolution of Novel Corona Virus 2019.
C7677609 ?. Evolutionary and Structural Studies of NCoV and SARS CoV-Spike proteins and their association with ACE2 Receptor.
C7717355 ?. Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma.
C7717363 ?. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients with COVID-19.
33333460 2021. Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children Associated With COVID-19.
C7717369 ?. Significant reduction of humoral response to SARS-CoV-2 4 months after the diagnosis of COVID-19.
C7607336 2020. O03?A case of hyperinflammatory COVID-19 that responded to tocilizumab therapy.
C7607334 2020. EP10?Hyperinflammatory syndrome in a patient with rheumatoid arthritis and COVID-19.
C7607308 2020. O01?Adult onset PIMS-TS with secondary haemophagocytic lymphistiocytosis: into the eye of the cytokine storm.
33309104 ?. Using Genetics To Dissect SARS-CoV-2 Infection.
C7665770 ?. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation.


32921750 2020. Iron overload and Hepcidin overexpression could play a key role in COVID infection, and may explain vulnerability in elderly, diabetics, and obese patients.
33219817 2020. Individuals With Less Severe Manifestations of SARS-CoV-2 Infection May Not Develop Long-Lasting Humoral Immunity.
33303190 2020. The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
33299872 2020. Phylogenomics Analysis of SARS-CoV2 Genomes Reveals Distinct Selection Pressure on Different Viral Strains.
33299503 2020. An Immunoinformatics Study to Predict Epitopes in the Envelope Protein of SARS-CoV-2.
33299631 2020. Varying Presentations of Multisystem Inflammatory Syndrome Temporarily Associated with COVID-19.
33274096 2020. Multisystem Inflammatory Syndrome in Children in a 15-Year-Old Male with a Retropharyngeal Phlegmon.
33298836 2020. RNA 2'-O-methylation modification and its implication in COVID-19 immunity.
33298900 2020. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro.
33301717 2020. FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein.
33306985 2020. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.
33112651 2020. Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children.
33257339 2020. Le syndrome inflammatoire multisystemique de l'enfant ayant un lien temporel avec la COVID-19 : multiples visages, multiples appellations.
33304243 2020. Neuropathobiology of COVID-19: The Role for Glia.
33281831 2020. The Role of Structure in the Biology of Interferon Signaling.
33089820 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) - Recent Updates.
33302033 2020. The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.
33299610 2020. SARS-CoV-2, Early Entry Events.
33303307 2020. Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution?
33173546 2020. Hyperinflammation bei SARS-CoV-2-Infektion.
32503876 2020. T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection.


33253656 2020. One year update on the COVID-19 pandemic: Where are we now?
33230418 2020. Characteristics and considerations in the medical treatment of COVID-19 in children.
33169815 2020. Basics of mechanical ventilation for non-anaesthetists. Part 1: Theoretical aspects.
33279488 2020. The Utility of CHA(2)DS(2)-VASc Scores as a Risk Assessment Tool in Low-Risk In-Hospital Patients With Coronavirus Disease 2019 Infection.
33197639 2020. Our insight about Mukhtar et al.'s outcome of non-invasive ventilation in COVID-19 critically ill patients.
33242934 2020. Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure. A single-centre case series.
33245382 2020. Empfehlungen fur die Behandlung von kritisch kranken Patienten mit COVID-19 : Version 3 S1-Leitlinie.
33241252 2020. Knowledge and Confidence Level Among Emergency Healthcare Workers in Airway Management and Resuscitation of Suspected COVID-19 Patients: A Cross Sectional Study in Malaysia.
33264802 2020. Ambulatory Clinician's Guide to Inpatient Service: An Innovative Rapid Onboarding Strategy for the COVID-19 Pandemic.
33272716 2020. Surgical strategy and optimal timing of tracheostomy in patients with COVID-19: Early experiences in Japan.
33294449 2020. Differences in Clinical Features and Laboratory Results between Adults and Children with SARS-CoV-2 Infection.
33256643 2020. A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients.
33287804 2020. Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: a population-based cohort study.
33272250 2020. Comparative analysis of COVID-19 guidelines from six countries: a qualitative study on the US, China, South Korea, the UK, Brazil, and Haiti.
33293361 2020. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA.
33223045 2020. Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery.
33254199 2020. Hemodynamic and mechanical ventilation approach in patients with COVID-19.
33263635 2020. Update on the diagnosis and management of COVID-19 in pediatric patients.
33287864 2020. Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome.
33283196 2020. A Novel Low-Cost Ventilator for Use in a Worldwide Pandemic: The Portsmouth Ventilator.
33278017 2020. Inpatient Hyperglycemia Management and COVID-19.
33273040 2020. Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: a substudy of the PRIEST observational cohort study.
33282444 2020. Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients: A Multi-Center Retrospective Study in China.
33257913 2020. Veno-venous extracorporeal membrane oxygenation in coronavirus disease 2019: a case series.
33257912 2020. Continuous positive airway pressure-treated patients' behaviours during the COVID-19 crisis.
33293151 2020. Home-based COVID 19 management: A consensus document from Italian general medical practitioners and hospital consultants in the Lombardy region (Italy).
33275268 2020. Extracorporeal membrane oxygenation (ECMO) in patients with COVID-19: a rapid systematic review of case studies.
33230401 2020. Inclusive Biomedical Innovation during the COVID-19 Pandemic.
33271960 2020. What Can COVID-19 Teach Us about Using AI in Pandemics?
33281326 2020. Modified Negative Airflow Aerosol Prevention Box for COVID-19 Patients.
33281316 2020. Noninvasive Oxygen Strategies to Manage Confirmed COVID-19 Patients in Indian Intensive Care Units: A Survey.
33281314 2020. Awake Prone Positioning in COVID-19 Patients.
33281309 2020. Role of Noninvasive Oxygen Therapy Strategies in COVID-19 Patients: Where are We Going?
33281307 2020. Conscious Proning or Mixed Positioning for Improving Oxygenation-COVID-19 Brings Many Changes!
33289013 2020. Outlier-SMOTE: A refined oversampling technique for improved detection of COVID-19.
33287859 2020. Criteria for referral of pediatric SARS-CoV-2 infection: a real-life experience in the pandemic era.
33277163 2020. Performing Ultrasound-Guided Percutaneous Tracheostomy in COVID-19 Patients.
33185672 2020. Ensemble learning for poor prognosis predictions: a case study on SARS-CoV2.
33288431 2020. Con: Venoarterial ECMO Should Not Be Considered in Patients With COVID-19.
33288430 2020. Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19.
33262038 2020. Acute Respiratory Distress Syndrome Treated With Awake Extracorporeal Membrane Oxygenation in a Patient With COVID-19 Pneumonia.
33282650 2020. Pulmonary Embolism in COVID-19 Pneumonia: An Overlapping Diagnosis or a Misdiagnosis?
33274414 2020. Derivation of a Clinical Risk Score to Predict 14-Day Occurrence of Hypoxia, ICU Admission, and Death Among Patients with Coronavirus Disease 2019.
33268203 2020. A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance.
33284779 2020. Artificial Intelligence in the Fight against COVID-19: A Scoping Review.
33273946 2020. Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment.
33282011 2020. How chemical engineers can contribute to fight the COVID-19.
33256918 2020. SARS-CoV-2 risk misclassification explains poor COVID-19 management.
33276832 2020. Noninvasive Positive Pressure Ventilation in Patients With COVID-19.
33254558 2020. Role of graphene in biosensor and protective textile against viruses.
33254485 2020. The "COVID-19 Score" can predict the need for tracheal intubation in critically ill COVID-19 patients - A hypothesis.
33295326 2020. Silent or 'Happy' Hypoxemia: An Urgent Dilemma for COVID-19 Patient Care.
33285690 2020. Successful treatment of a critically ill patient with acute respiratory distress syndrome from COVID-19 using mechanical ventilation strategy with low levels of positive end-expiratory pressure: A CARE-compliant case report.
33282284 2020. COVID-19: general overview, pharmacological options and ventilatory support strategies.
33283160 2020. "Neurological manifestations of COVID-19" - guideline of the German society of neurology.
33274248 2020. The BAS(2)IC Score: A Useful Tool to Identify Patients at High Risk of Early Progression to Severe Coronavirus Disease 2019.
33294107 2020. Preventing Acute Respiratory Distress Syndrome (ARDS) and to avoiding intubation in patients with COVID-19: an experience from a reanimation service in Morocco.
33263088 2020. Chest Tube Drainage in the Age of COVID-19.
33296409 2020. COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2.
33296405 2020. COVID-19 mortality risk assessment: An international multi-center study.
33296357 2020. Development and external validation of a prognostic tool for COVID-19 critical disease.
33259540 2020. Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation-A protocol for a randomized controlled pilot study.
33262075 2020. Effects of prone and lateral position in non-intubated patients with 2019 Novel Coronavirus (COVID-19) pneumonia.
33272911 2020. Wearing of medical mask over the high-flow nasal cannula for safer oxygen therapy in the COVID-19 era.
33294226 2020. From Radiological Manifestations to Pulmonary Pathogenesis of COVID-19: A Bench to Bedside Review.
33288840 2020. Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19.
33260852 2020. ResUHUrge: A Low Cost and Fully Functional Ventilator Indicated for Application in COVID-19 Patients.
33262803 2020. Prone-Position Ventilation in a Pregnant Woman with Severe COVID-19 Infection Associated with Acute Respiratory Distress Syndrome.
33262795 2020. NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals.
33249683 2020. Derivation with Internal Validation of a Multivariable Predictive Model to Predict COVID-19 Test Results in Emergency Department Patients.
33296169 2020. Recent Insights into Emerging Coronavirus: SARS-CoV-2.
33247469 2020. Coronaviruses in Children: A Review of Potential Mechanisms of Childhood Protection.
33205450 2020. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19.
33284040 2020. Novel Tracheostomy and Percutaneous Endoscopic Gastrostomy Technique for COVID-19 Patients in a Nonnegative Pressure Environment.
33283190 2020. Awake proning of a 2-year-old extubated child with severe COVID-19 pneumonitis.
33274761 2020. Are tracheal intubation and extubation aerosol-generating procedures?
33288635 2020. Evidence-Based Guidelines Should Be Used to Inform COVID-19 Management.
33262177 2020. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.
33277976 2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 2.
33256990 2020. Controversies in airway management of COVID-19 patients: updated information and international expert consensus recommendations.
33255120 2020. Positive End-Expiratory Pressure in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Higher May Be Too High.
33278112 2020. Epidemiologic trends and characteristics of SARS-CoV-2 infections among children in the United States.
33231148 2020. Respiratory Therapeutic Strategies in Children and Adolescents with COVID-19: a Critical Review.
33183207 2020. COVID-19 and Comorbidities: is Inflammation the Underlying Condition in Children? A narrative Review.
33238869 2020. Therapeutic management of COVID-19 patients: Clinical manifestation and limitations.
33280586 2020. COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review.
33273392 2021. Reply to: video laryngoscopy during airway management in COVID-19 patients.
33273391 2021. Video laryngoscopy during airway management in COVID-19 patients: practical relevance of a recent EJA Christmas issue article.
33257600 2020. What is the Determinant of 2019 Novel Coronavirus Prognosis in Children?
33257599 2020. Duration of Viral Clearance in Children With SARS-CoV-2 Infection in Rajasthan, India.
33278855 2020. COVID-19; current situation and recommended interventions.
33291198 2020. A Patient with COVID-19 Treated with ECMO for 26 Days.
33257957 2020. COVID 19: Trends, Disparities, and Consequences for Older Adults.
33285451 2020. Novel expandable architected breathing tube for improving airway securement in emergency care.
33289142 2020. Development and Validation of a Nomogram Using on Admission Routine Laboratory Parameters to Predict In-hospital Survival of Patients With COVID-19.
33259470 2020. Implementing Prone Positioning for COVID-19 Patients Outside the Intensive Care Unit.
33280024 2020. Paediatric COVID-19: Milder Presentation-A Silver Lining in Dark Cloud.
33295047 2020. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group.
33295002 2020. Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group.
33288946 2020. COVID-19: what health experts could and could not predict.
33280533 2020. Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolism.
33226885 2020. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
33264801 2020. Score to Assess the Risk of Pneumonia in Coronavirus Disease-19.


33205948 2020. Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry.
33186121 2020. Comparative analysis of SARS-CoV-2 and its receptor ACE2 with evolutionarily related coronaviruses.
33231569 2020. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
33203793 2020. Cell differentiation and aging accompanied by depletion of the ACE2 protein.
33237794 2020. Immunoglobulin Deficiency as an Indicator of Disease Severity in Patients with COVID-19.
33082620 2020. Insights into the Immunopathophysiology of Severe COVID-19 in Metabolic Disorders.
33183023 2020. Morphological changes of lymphocytes in peripheral blood smears of patients with COVID-19.
33240994 2020. Dynamic changes of T-lymphocyte subsets and the correlations with 89 patients with coronavirus disease 2019 (COVID-19).
33145296 2020. Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study.
33231054 2020. Recomendaciones para el manejo inicial del sindrome inflamatorio multisistemico relacionado temporalmente con COVID-19, en ninos y adolescentes.
33201341 2020. ceRNA analysis of SARS-CoV-2.
33190827 2020. T cell immunity to SARS-CoV-2 following natural infection and vaccination.
33220925 2020. T-cell dysregulation in COVID-19.
33187644 2020. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
33234239 2020. Host-directed editing of the SARS-CoV-2 genome.
33199022 2020. The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
33220921 2020. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
33027600 2020. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.
33189832 2020. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response.
33066821 2020. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein.
33224987 2020. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.
33225414 2020. (1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "the N-terminal domain-SUD-N".
33219414 2020. (1)H, (13)C, and (15)N backbone and side chain chemical shift assignments of the SARS-CoV-2 non-structural protein 7.
33191083 2020. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
33253634 2020. A Multiscale Coarse-grained Model of the SARS-CoV-2 Virion.
33189680 2020. The Flexibility of ACE2 in the Context of SARS-CoV-2 Infection.
33152090 2020. COVID-19-induced atypical pulmonary lymphocytes.
33119481 2020. Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents.
33097885 2020. Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2.
33188677 2020. Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection.
33207184 2020. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
33232691 2020. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.
33245857 2020. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies.
33242391 2020. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles.
33207245 2020. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in beta Cells.
33207244 2020. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19.
33220791 2020. The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein.
33232663 2020. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.
33196989 2020. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
33238570 2020. The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.
33217417 2020. Lower respiratory tract myeloid cells harbor SARS-CoV-2 and display an inflammatory phenotype.
33203513 2020. An enlightening role for cytokine storm in coronavirus infection.
33253854 2020. Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.
33189887 2020. Major reduction of NKT cells in patients with severe COVID-19 pneumonia.
32496544 2020. Evaluating Immune Dysregulation in Patients With COVID-19 Requires a More Accurate Definition of the CD45RA+ T-cell Phenotype.
33217259 2020. Case Report: Pediatric Patient with COVID-19 and Multisystem Inflammatory Syndrome in Children.
33209300 2020. Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.
33162723 2020. Stability Analysis in COVID-19 Within-Host Model with Immune Response.
33221119 2020. Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism.
33200028 2020. Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization.
33217169 2020. A Prototype QSP Model of the Immune Response to SARS-CoV-2 for Community Development.
33240687 2020. Multisystem Inflammatory Syndrome in Children, the Real Disease of COVID-19 in Pediatrics - A Multicenter Case Series From Al-Ahsa, Saudi Arabia.
33214962 2020. Kawasaki Disease-Like Features in 10 Pediatric COVID-19 Cases: A Retrospective Study.
33194461 2020. A Rare Presentation of Multi-System Inflammatory Disease in Children Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
33242255 2020. An integrative analysis identifying transcriptional features and key genes involved in COVID-19.
33253796 2020. The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.
33220345 2020. Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.
33207533 2020. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
33237152 2020. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses.
33239605 2020. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
33203641 2020. COVID-19 cytokine storm: what is in a name?
33232209 2020. Megakaryocytes: Masters of Innate Immunity?
33199021 2020. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.
33249673 2020. Specialized proresolving mediators in infection and lung injury.
33244583 2020. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.
33205194 2020. The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization.
33248129 2020. From Examining the Relationship between (Corona)Viral Adhesins and Galectins to Glyco-Perspectives.
33243116 2020. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
33186231 2021. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
33186230 2021. Molecular epidemiology in the HIV and SARS-CoV-2 pandemics.
33200826 2020. SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.
33202024 2020. Metabolic Syndrome and COVID-19: Endocrine-Immune Vascular Interactions Shape the Clinical Course.
33251605 2020. Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.
33182073 2020. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
33246355 2020. A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression.
33234246 2020. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections.
33111578 2020. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
33155525 2020. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
33191813 2020. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
33215821 2020. COVID-19: where have the lymphocytes gone?
33254234 2020. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.
33247640 2020. Post COVID Inflammation Syndrome: Different Manifestations Caused by the Virus.
33249452 2020. New Horizons: Does Mineralocorticoid Receptor activation by cortisol cause ATP release and COVID-19 complications?
33184940 2020. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.
33208459 2020. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.
33208457 2020. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
33249471 2020. Serum protein profiling reveals a specific upregulation of the immunomodulatory protein progranulin in COVID-19.
33206973 2020. Monocyte CD169 expression as a biomarker in the early diagnosis of COVID-19.
33197260 2020. Early plasma IL-37 responses accompanied with low inflammatory cytokines correlate with benign clinical outcomes during SARS-CoV-2 infection.
33211354 2020. Atypical monocytes in COVID-19: Lighting the fire of cytokine storm?
33252101 2020. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.
33188394 2020. SARS-CoV-2 triggering severe ARDS and secondary HLH in a 3-year-old child with Down syndrome.
33234675 2020. Structure of nonstructural protein 1 from SARS-CoV-2.
33237291 2020. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
33211045 2020. A digital protein microarray for COVID-19 cytokine storm monitoring.
33220726 2020. Kinetics and seroprevalence of SARS-CoV-2 antibodies in children.
33245861 2020. Herd immunity for COVID-19.
33185926 2020. SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.
33242097 2020. Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Case Report on Managing the Hyperinflammation.
33188728 2020. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
33244183 2020. Deciphering the ins and outs of SARS-CoV-2-specific T cells.
33208929 2020. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.
33184509 2020. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells.
33244168 2020. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
33199863 2020. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
33253058 2020. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.
33236427 2020. Immunological basis of virus-host interaction in COVID-19.
33222290 2020. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.
33249696 2020. Kawasaki disease mimickers.
33184170 2020. MIS-C and Cardiac Conduction Abnormalities.
33239446 2020. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.
33203681 2020. Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.


33048448 2020. Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.
33246770 2020. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
33199178 2020. A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted.
33186810 2020. A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways.
33231169 2020. COVID-19 research risks ignoring important host genes due to pre-established research patterns.
33205709 2020. Loss of orf3b in the circulating SARS-CoV-2 strains.
33179566 2020. Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.
33131453 2020. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.
33118859 2020. A SARS-CoV-2 variant with the 12-bp deletion at E gene.
33245471 2020. Expression and co-expression analyses of TMPRSS2, a key element in COVID-19.
33250893 2020. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.
33042918 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome.
33251267 2020. A Mini-Review on Cell Cycle Regulation of Coronavirus Infection.
33224264 2020. Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection.
33244382 2020. Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients.
33244381 2020. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine.
33244380 2020. Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.
33242394 2020. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity.
33232865 2020. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
33239109 2020. Increased circulating level of interleukin-6 and CD8(+) T cell exhaustion are associated with progression of COVID-19.
33249264 2020. Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2.
33206207 2020. Histamine receptors and COVID-19.
33072849 2020. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes.
33221169 2020. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
33227512 2020. Low dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19.
33202218 2020. Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.
33207699 2020. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
33043312 2020. Synthea Novel coronavirus (COVID-19) model and synthetic data set.
33251489 2020. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.
33236586 2020. Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives.
33236584 2020. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
33221383 2020. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
33229438 2020. The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.
33214224 2020. SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.
33243941 2020. Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19.
33245474 2020. N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects.
33216734 2020. Does common cold coronavirus infection protect against severe SARS-CoV2 disease?
33233425 2020. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.
33231615 2021. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
33242672 2020. Cytokine storm of a different flavor: the different cytokine signature of SARS-CoV2 the cause of COVID-19 from the original SARS outbreak.
33238745 2020. A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19.
33245961 2020. Structural insights into SARS-CoV-2 proteins.
33250660 2020. Thermal and hydrodynamic properties of coronavirus at various temperature and pressure via molecular dynamics approach.
33252688 2020. Race/Ethnicity Among Children With COVID-19-Associated Multisystem Inflammatory Syndrome.
33220289 2020. High GRP78 levels in Covid-19 infection: A case-control study.
33246692 2020. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival.
33231720 2020. Lungenveranderungen bei COVID-19 - Storung des pulmonalen Surfactants? : Eine nicht ganz weit hergeholte Hypothese.
33242646 2020. Structural and functional insights into non-structural proteins of coronaviruses.
33237893 2020. Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020.
33248025 2020. Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.
33242581 2020. The phylogenetic relationship within SARS-CoV-2s: an expanding basal clade.
33200082 2020. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.
33239366 2020. Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets.
33247152 2020. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
33247108 2020. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
33243994 2020. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
33239633 2020. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2.
33208793 2020. SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography.
33208736 2020. Architecture of a SARS-CoV-2 mini replication and transcription complex.
33208735 2020. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site.
33203890 2020. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.
33203833 2020. Immune suppression in the early stage of COVID-19 disease.
33160723 2020. Sustancia P, citocinas proinflamatorias, receptor de potencial transitorio vaniloide tipo 1 y COVID-19: una hipotesis de trabajo.
33230417 2020. SARS-COV2 and P. falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.
33244341 2020. An elevated 8-isoprostaglandin F2 alpha (8-iso-PGF2alpha) in COVID-19 subjects co-infected with malaria.
33198594 2020. Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.
33131800 2020. Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.
33202215 2020. Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.
33206635 2020. Stability of SARS-CoV-2 phylogenies.
33253226 2020. SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia.
33232382 2020. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
33211781 2020. Antibody profiling and prevalence in US patients during the SARS-CoV2 pandemic.
33201914 2020. Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam.
33035234 2020. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
33237441 2020. Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody.
33219837 2020. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
33239683 2020. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.
33199778 2020. Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19.
33060566 2020. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
33203855 2020. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins.
33251482 2020. Acute Kidney Injury in Multisystem Inflammatory Syndrome in Children (MIS-C): a Case Report.
33235185 2020. Influence of social isolation caused by coronavirus disease 2019 (COVID-19) on the psychological characteristics of hospitalized schizophrenia patients: a case-control study.
33221483 2020. The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.
33214057 2020. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
33207583 2020. Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals.
33198287 2020. SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors.
33232769 2020. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
33210477 2020. Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review.
33225958 2020. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
33235813 2020. Temporal signal and the phylodynamic threshold of SARS-CoV-2.
33227343 2020. Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.
33114742 2020. Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization.
33207802 2020. Recombination and Positive Selection Differentially Shaped the Diversity of Betacoronavirus Subgenera.
33184176 2020. The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
33184173 2020. Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations.
33231324 2020. Prefusion spike protein stabilization through computational mutagenesis.
33174706 2020. Les strategies subversives utilisees par SARS-CoV-2 pour supprimer les defenses de l'hote.
33174705 2020. Covid-19: que sait-on de la reponse immune humorale au virus SARS-CoV-2 ?
33205496 2020. Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.
33197261 2020. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.
33205718 2020. Multisystem inflammatory syndrome in adult COVID-19 patients.
33208380 2020. The known unknowns of T cell immunity to COVID-19.
33184193 2020. Enhancing host cell infection by SARS-CoV-2.
33184236 2020. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.
33207070 2020. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.
33215583 2020. [Multisystem inflammatory syndrome in children after SARS-CoV-2 infection].
33202195 2020. Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19.
33198855 2020. [Analysis of pathogenesis, syndrome differentiation and treatment of asymptomatic infectors of coronavirus disease 2019 based on the theory of "pathogen hiding in the pleurodiaphragmatic interspace"].


33042442 2020. Transcription factor-mediated signaling pathways' contribution to the pathology of acute lung injury and acute respiratory distress syndrome.
33034338 2020. Computer-aided prediction and design of IL-6 inducing peptides: IL-6 plays a crucial role in COVID-19.
33126244 2020. Compositional diversity and evolutionary pattern of coronavirus accessory proteins.
33110251 2020. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response.
33060840 2020. Unique immunological profile in patients with COVID-19.
33139905 2020. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.
33037400 2020. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.
33139926 2020. The SARS-CoV-2 spike protein: balancing stability and infectivity.
33077165 2020. Editorial overview: Membrane traffic in the time of COVID-19.
33071044 2020. Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
33029657 2020. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study.
33023827 2020. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.
33158808 2020. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology.
33038769 2020. The role for the metagenome in the pathogenesis of COVID-19.
33050983 2020. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
33083436 2020. Does inflammation help during COVID-19?
33107217 2020. Delayed acute myocarditis and COVID-19-related multisystem inflammatory syndrome.
33162632 2020. Are dopamine and serotonin involved in COVID-19 pathophysiology?
33149541 2020. New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release.
33171276 2020. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
33118022 2020. Molecular diversity of coronavirus host cell entry receptors.
33038530 2020. The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
33194826 2020. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA.
33123498 2020. Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities.
33072624 2020. The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection.
33178720 2020. Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+CD66b- Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19.
33178021 2020. Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease.
32974267 2020. An Overview of the Temporal Shedding of SARS-CoV-2 RNA in Clinical Specimens.
33085541 2020. Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs.
33163695 2020. Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh.
33173592 2020. A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2.
33135055 2020. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
33139855 2020. The pivotal role of the angiotensin-II-NF-kappaB axis in the development of COVID-19 pathophysiology.
33163360 2020. A fatal course of multiple inflammatory syndrome in children coinfection with dengue. A case report from Indonesia.
33040752 2020. Whither immunity? The search for effective, durable immunity to coronavirus disease 2019 (COVID-19).
33039603 2020. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex.
33035643 2020. Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.
32937193 2020. Quasi-species nature and differential gene expression of severe acute respiratory syndrome coronavirus 2 and phylogenetic analysis of a novel Iranian strain.
33079210 2020. Inflammasome formation in the lungs of patients with fatal COVID-19.
33029758 2020. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.
33159646 2020. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
33131215 2020. What is the long-term clinical significance of anti-SARS-CoV-2-specific IgG?
33039966 2020. Continuous tracking of COVID-19 patients' immune status.
33039965 2020. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study.
33068863 2020. Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19).
33068865 2020. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.
33058970 2020. Papain-like cysteine proteinase zone (PCP-zone) and PCP structural catalytic core (PCP-SCC) of enzymes with cysteine proteinase fold.
33061814 2020. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
33076729 2020. Immune system changes during COVID-19 recovery play key role in determining disease severity.
33115680 2020. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia.
33075532 2020. Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity.
33176202 2020. High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa.
33160066 2020. Viral Kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period.
33057783 2020. Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview.
33099545 2020. Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies.
33043283 2020. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum.
33134888 2020. SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases.
33122196 2020. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity.
33060199 2020. Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.
33051211 2020. Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity.
33154165 2020. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment.
33161818 2020. The Circadian Clock and Viral Infections.
33145472 2020. SARS-CoV-2 (COVID-19) and the Endocrine System.
32910820 2020. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
33128369 2020. Analysis of humoral immune responses in SARS-CoV-2 infected patients.
33122141 2020. Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study.
33099199 2021. Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model.
33135884 2020. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
33103907 2020. Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients.
33103435 2020. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
32946692 2020. Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.
33169633 2020. Angiotensin II, III, and IV may be important in the progression of COVID-19.
33035201 2020. Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors.
33129392 2020. Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
33129391 2020. Host or pathogen-related factors in COVID-19 severity?
33129826 2020. Immunity after COVID-19: Protection or sensitization?
33049594 2020. Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology.
33112981 2020. Interdisziplinares COVID-Board bei SARS-CoV-2-getriggerter hyperferritinamischer Inflammation.
33083157 2020. Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load.
32983652 2020. Potential role of cellular miRNAs in coronavirus-host interplay.
33065209 2020. The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection.
33137344 2020. Human coronavirus spike protein-host receptor recognition.
33106987 2020. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review.
33098476 2020. An Overview of the Crystallized Structures of the SARS-CoV-2.
33181413 2020. High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients.
33058760 2020. The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET.
33189428 2020. Duration of anti-SARS-CoV-2 antibodies much shorter in India.
33164796 2020. Identification of a dominant CD8(+) CTL epitope in the SARS-associated coronavirus 2 spike protein.
33050053 2020. Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy.
33036202 2020. Host Receptors of Influenza Viruses and Coronaviruses-Molecular Mechanisms of Recognition.
33041736 2020. Glicosilacion, sitios de union de ligandos y variaciones antigenicas entre la glicoproteina de membrana del COVID-19 y los coronavirus asociados.
33121513 2020. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.
33059711 2020. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
33164536 2020. Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19?
33108121 2020. Lecons biochimiques et statistiques de l'evolution du virus SARS-CoV-2 : nouveaux chemins pour combattre les virus.
33064620 2020. The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization.
33166547 2020. A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.
33176080 2020. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
33077916 2020. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
33077915 2020. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option.
33169014 2020. Proinflammatory IgG Fc structures in patients with severe COVID-19.
33139917 2020. Overlapping B cell pathways in severe COVID-19 and lupus.
33028979 2020. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.
32855347 2020. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome.
33115920 2020. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
33093098 2020. The engines of SARS-CoV-2 spread.
33060197 2020. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
33159009 2020. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
33082295 2020. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
33082294 2020. Neuropilin-1 is a host factor for SARS-CoV-2 infection.
33082293 2020. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
33147933 2020. [Progress in research on cytokine storm].


33140034 2020. Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein.
33166035 2020. The role of senescent T cells in immunopathology.
33041634 2020. Characterization of SARS-CoV-2 Dynamics in the Host.
33178900 2020. SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes.
33072893 2020. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
33039147 2020. High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
33097184 2020. Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
33069360 2020. Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies.
33138856 2020. Serological determinants of COVID-19.
33153065 2020. Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients.
33120236 2020. Innate and adaptive immune responses against coronavirus.
33102591 2020. Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus.
33143053 2020. miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19.
33159807 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10.
33142431 2020. A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules.
33035469 2020. COVID-19 in children: a case report of Multisystem Inflammatory Syndrome (MIS-C) in Sao Paulo, Brazil.
33038939 2020. Cytokine Storms in Cancer and COVID-19.
33101705 2020. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing.
33031765 2020. Mining the Antibody Repertoire for Solutions to SARS-CoV-2.
33096026 2020. Large-Scale Multi-omic Analysis of COVID-19 Severity.
33138195 2020. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
33086697 2020. Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability.
33171736 2020. Cell Biology of Viral Infections.
33087172 2020. The epigenetic implication in coronavirus infection and therapy.
33069853 2020. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children.
33147319 2020. Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons.
33123353 2020. Complement and protection from tissue injury in COVID-19.
33049415 2020. Cardiovascular magnetic resonance imaging in children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 and heart dysfunction.
33144203 2020. Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain.
33055229 2020. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
33072323 2020. Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity.
33135345 2020. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.
32965311 2020. Hemophagocytic syndrome: a potential COVID-19 complication.
33066459 2020. Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).
33147321 2020. An unconventional view of COVID-19 T cell immunity.
32999425 2020. Response to "the role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection".
33031080 2020. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
33140086 2020. Longitudinal analysis of serology and neutralizing antibody levels in COVID19 convalescents.
33116747 2020. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
33046418 2020. Antibody response to SARS-CoV-2 in people living with HIV.
33082599 2020. Chloroquine and hydroxychloroquine inhibitors for COVID-19 sialic acid cellular receptor: Structure, hirshfeld atomic charge analysis and solvent effect.
33157499 2020. Detailed immune monitoring of a pregnant woman with critical Covid-19.
33130538 2020. Can immunity during pregnancy influence SARS-CoV-2 infection? - A systematic review.
33158944 2020. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
33144321 2020. Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
33170317 2020. ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
33163958 2020. Comparative analysis of nanomechanical features of coronavirus spike proteins and correlation with lethality and infection rate.
33127861 2020. Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.
33067385 2020. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
33067384 2020. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
33184103 2020. Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2.
33146390 2020. Characterizing transcriptional regulatory sequences in coronaviruses and their role in recombination.
33047062 2020. Designing of cytotoxic and helper T cell epitope map provides insights into the highly contagious nature of the pandemic novel coronavirus SARS-CoV-2.
33163105 2020. Analyses genomiques et phylodynamiques du Sars-CoV-2.
33113222 2020. T cell immunobiology and cytokine storm of COVID-19.
33187979 2020. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.
33106497 2020. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
33082451 2020. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
33077873 2020. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients.
33077837 2020. Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.
33067518 2020. Quantifying the adhesive strength between the SARS-CoV-2 S-proteins and human receptor and its effect in therapeutics.
33184506 2020. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19).
33177594 2020. SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
33173052 2020. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.
33037188 2020. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
33037187 2020. Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2.
33127889 2020. SARS-CoV-2 spike protein: flexibility as a new target for fighting infection.
33127886 2020. SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic.
33043252 2020. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19.
33106783 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: a New Challenge amid the Pandemic.
33195997 2020. Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.
33041212 2020. Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions.
33153908 2020. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
33132005 2020. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.
33190685 2020. The Mystery of MIS-C Post-SARS-CoV-2 Infection.
33077340 2020. Sex-biased Immune Responses Following SARS-CoV-2 Infection.
33051104 2020. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
33029383 2020. Intra-genome variability in the dinucleotide composition of SARS-CoV-2.
33050511 2020. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
33182268 2020. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
33147840 2020. First Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region.
33187074 2020. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses.
33067221 2020. Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.
33023959 2020. Response to 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort by Mastrolia et al.
33086866 2020. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart.
33181224 2020. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.
33105999 2020. Computer simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces.
33139323 2020. Covid-19: T cell response lasts for at least six months after infection, study shows.
33084150 2020. Why Does the Novel Coronavirus Spike Protein Interact so Strongly with the Human ACE2? A Thermodynamic Answer.
33174669 2020. Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex.
33081670 2020. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
33164997 2020. Inflammatory endotypes of CRSwNP and responses to COVID-19.
33165008 2020. The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2.
33145867 2020. Immunology of COVID-19.
33174592 2020. Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
33155530 2020. SARS-CoV-2 mutations and where to find them: an in silico perspective of structural changes and antigenicity of the spike protein.
33162259 2020. Multisystem Inflammatory Syndrome in Children.
33086932 2020. The bumpy road to achieve herd immunity in COVID-19.
33148714 2020. SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
33083826 2020. Associations between genetically predicted protein levels and COVID-19 severity.
33038254 2020. Complement activation in the disease course of COVID-19 and its effects on clinical outcomes.
33135795 2020. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
33180935 2020. Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19.
33175159 2020. Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in an 8-week old infant.
33075008 2020. Private Tour Guide to Pediatric Coronavirus Disease of 2019 and Multisystem Inflammatory Syndrome in Children in 10 Minutes: What Thoracic Radiologists Need to Know.
33141192 2020. Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses.
33074293 2020. Herd Immunity and Implications for SARS-CoV-2 Control.
33106674 2020. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
33177698 2020. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.
33106671 2020. Spike mutation D614G alters SARS-CoV-2 fitness.
33139913 2020. Interferon deficiency can lead to severe COVID.
33084624 2020. Immune Responses During Human Coronavirus Infection: Suggestions for Future Studies.


33108239 2020. Can secondary lymphoid organs exert a favorable effect on the mild course of COVID-19 in children?
33090696 2020. Sex differences in antiviral immunity in SARS-CoV-2 infection: Mitochondria and mitomiR come into view.
33065551 2020. CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients.
33049711 2020. Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner.
33040337 2020. Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections.
33131972 2020. Multisystem inflammatory syndrome in children associated with novel coronavirus SARS-CoV-2: Presentations to a pediatric emergency department in Michigan.
33151090 2020. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of COVID-19 patients.
33146564 2020. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
33174447 2020. In well-differentiated primary human bronchial epithelial cells, TGF-beta1 and TGF-beta2 induce expression of furin.
33132066 2020. Documento espanol de consenso sobre diagnostico, estabilizacion y tratamiento del sindrome inflamatorio multisistemico pediatrico vinculado a SARS-CoV-2 (SIM-PedS).
33134148 2020. Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report.
33161155 2020. Potential Association of Mast Cells with COVID-19.
33025199 2020. Identification of novel mutations in SARS-COV-2 isolates from Turkey.
33130000 2020. SARS-CoV-2, the autoimmune virus.
33153403 2020. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
33152343 2020. Detection of Viral Infections by Innate Immunity.
33161004 2020. Special section involvement of lipids in the occurrence of COVID-19.
33159981 2020. Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses.
33115667 2020. Membrane heist: Coronavirus host membrane remodeling during replication.
33075136 2020. Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.
33146371 2020. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.
33090599 2020. Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown.
33088822 2020. SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock.
33072741 2020. How to Understand "Herd Immunity" in COVID-19 Pandemic.
33042994 2020. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
33195336 2020. Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications.
33195331 2020. The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences.
33195321 2020. Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.
33042039 2020. Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution.
33195436 2020. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.
33195427 2020. Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations.
33195415 2020. Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis.
33195414 2020. Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues.
33195401 2020. SARS-CoV-2 Virion Stabilization by Zn Binding.
33195400 2020. COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response.
33173781 2020. Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel.
33134318 2020. ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?
33088807 2020. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer.
33034002 2020. Cardiac Affection in a Young Girl with Post Covid-19 Kawasaki Like Syndrome.
33090321 2020. A Pediatric COVID19 Case with Suspected Acute Abdomen, Hyperferritinemic Sepsis and Developing MIS-C and Pancreatitis.
33078283 2020. Neurological Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).
33149633 2020. Exploring Diversity of COVID19 Based on Substitution Distance.
33036230 2020. Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2.
33063791 2020. Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures.
33063790 2020. Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL M(pro): insights into enzyme mechanism and drug design.
33145962 2020. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
33119547 2020. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.
33104057 2020. Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?
33116752 2020. Cytokine Response in SARS-CoV-2 Infection in the Elderly.
33054818 2020. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
33112147 2020. Critical Sequence Hotspots for Binding of Novel Coronavirus to Angiotensin Converter Enzyme as Evaluated by Molecular Simulations.
33085491 2020. Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands.
33134610 2020. In the Age of COVID: Genomic Changes Over the Lifespan Help Explain Severe SARS-CoV-2 Disease.
33073064 2020. Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells.
32984657 2020. Multiorgan Damage in Patients With COVID-19: Is the TGF-beta/BMP Pathway the Missing Link?
32950081 2020. A history of herd immunity.
33072868 2020. Cross-reactions between rheumatoid factor and IgM SARS-CoV-2.
33103107 2020. Protein-driven mechanism of multiorgan damage in COVID-19.
33110678 2020. Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor.
33061829 2020. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
33028028 2020. Positive Anti-SSA/Ro Antibody in a Woman with SARS-CoV-2 Infection Using Immunophenotyping: A Case Report.
33196005 2020. COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment.
33196004 2020. Kawasaki Disease and COVID-19.
33157216 2020. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.
33049387 2020. Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.
33093050 2020. Coding-Complete Genome Sequences of 23 SARS-CoV-2 Samples from the Philippines.
33066057 2020. Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection.
33147871 2020. New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract.
33077685 2020. Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.
33040198 2020. SARS-CoV-2 has the advantage of competing the iMet-tRNAs with human hosts to allow efficient translation.
33167852 2020. SARS-CoV-2 and interferon blockade.
33053318 2020. The Road Less Traveled: SARS-CoV-2 and Cell-Mediated Immunity.
33186542 2020. COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a(+).
33038327 2020. Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity.
33033248 2020. Two distinct immunopathological profiles in autopsy lungs of COVID-19.
33028810 2020. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.
33116139 2020. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.
33110068 2020. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation.
33046696 2020. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
33139888 2020. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models.
33051610 2020. IL-18-dependent MAIT cell activation in COVID-19.
33073555 2020. SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications.
33154981 2020. The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET.
33036180 2020. Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality.
33114356 2020. New Insights on the Mobility of Viral and Host Non-Coding RNAs Reveal Extracellular Vesicles as Intriguing Candidate Antiviral Targets.
33099164 2020. Atypical lymphocytes in bronchoalveolar lavage fluid from patients with COVID-19 ARDS.
33194341 2020. Excessive G-U transversions in novel allele variants in SARS-CoV-2 genomes.
33088633 2020. Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function.
32898168 2020. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
33170902 2020. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.
33091042 2020. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
33085715 2020. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
33079950 2020. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients.
33034798 2020. Whole genome sequencing and phylogenetic classification of Tunisian SARS-CoV-2 strains from patients of the Military Hospital in Tunis.
33166565 2021. Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome.
33069815 2020. The role of dysregulated immune responses in COVID-19 pathogenesis.
33180463 2020. COVID-19 in the Developing World: Is the Immune Response to alpha-Gal an Overlooked Factor Mitigating the Severity of Infection?
33073197 2020. Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity?
33112638 2020. Literature review on Virus and Host Response Proteins in COVID-19: Pathobiology, Management, Diagnosis and Treatment.
33112637 2020. Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV2.
33128792 2020. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
33105230 2020. Characteristics of Pediatric Inflammatory Multisystem Syndrome Associated with COVID-19.
33064955 2020. Will Research on COVID-19 Stimulate the Identification of Immunological Mechanisms Underlying Some Protective Effects?
33140827 2020. ACE2 and gut amino acid transport.
33044282 2020. Acute Kidney Injury in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Experience From PICUs Across United Kingdom.
33176273 2020. Detection of viruses by inflammasomes.
33023438 2020. miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.
33084029 2020. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.
33080068 2020. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
33073359 2020. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.
33152254 2020. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
33113212 2020. COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.


33096082 2020. Structure-Altering Mutations of the SARS-CoV-2 Frameshifting RNA Element.
33100352 2020. Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm.
33171100 2020. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
33157038 2020. beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
33147445 2020. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
33147444 2020. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
33096020 2020. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
33080218 2020. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
33037393 2020. An aberrant STAT pathway is central to COVID-19.
33110074 2020. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
33072409 2020. The role of death domain proteins in host response upon SARS-CoV-2 infection: modulation of programmed cell death and translational applications.
33024578 2020. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.
33158455 2020. Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care.
33138839 2020. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
33131507 2020. The double edged interferon riddle in COVID-19 pathogenesis.
33063036 2020. Delayed Development of Coronary Artery Dilitation in Suspected Severe Acute Respiratory Syndrome Coronavirus 2 Multisystem Inflammatory Syndrome: More Research Needed.
33145128 2020. A Case of Multisystem Inflammatory Syndrome in Children Mimicking Acute Appendicitis in a COVID-19 Pandemic Area.
33133836 2020. Atypical Case of COVID-19 Associated Kawasaki Disease in an Eight-Year-Old Pakistani Boy.
33110725 2020. Multisystem Inflammatory Syndrome in Children Temporally Related to COVID-19: A Case Report From Saudi Arabia.
33112236 2020. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
33103998 2020. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
33164753 2020. Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes.
33164751 2020. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.
33051876 2020. Syncytia formation by SARS-CoV-2-infected cells.
33078545 2020. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia.
33112036 2020. SARS-CoV-2 evades immune detection in alveolar macrophages.
33058753 2020. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
33083367 2020. Kawasaki-like Syndrome as an Emerging Complication of SARS-CoV-2 Infection in Young Adults.
33058143 2020. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
33038418 2020. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
33086029 2020. Renin-angiotensin system at the interface of COVID-19 infection.
33193414 2020. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
33193390 2020. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19.
33193384 2020. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
33193377 2020. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.
33193337 2020. COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions.
33193331 2020. A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
33178221 2020. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.
33178220 2020. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
33178207 2020. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
33178193 2020. Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
33163005 2020. The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.
33154753 2020. Elevated Exhaustion Levels of NK and CD8(+) T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.
33154751 2020. Coronavirus Proteins as Ion Channels: Current and Potential Research.
33149733 2020. The Inflammasome in Times of COVID-19.
33133104 2020. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients.
33133098 2020. Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases.
33133083 2020. Immune Correlates of COVID-19 Control.
33123167 2020. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
33123154 2020. Increased Plasma Heparanase Activity in COVID-19 Patients.
33123152 2020. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
33123149 2020. A "Window of Therapeutic Opportunity" for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019.
33117408 2020. The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.
33117402 2020. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
33117392 2020. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
33117379 2020. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19.
33117378 2020. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens.
33101320 2020. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
33101306 2020. Covid-19: Perspectives on Innate Immune Evasion.
33072103 2020. Immunopathogenesis of COVID-19: Summary and Possible Interventions.
33072099 2020. Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology.
33072097 2020. COVID-19: In the Eye of the Cytokine Storm.
33042116 2020. COVID-19: Infection or Autoimmunity.
33098549 2020. Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges.
33086021 2020. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus.
33125064 2020. A path towards SARS-CoV-2 attenuation: metabolic pressure on CTP synthesis rules the virus evolution.
33069829 2020. Clustering and classification of virus sequence through music communication protocol and wavelet transform.
33161087 2020. Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus.
33124193 2020. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
33163249 2020. The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene.
33129373 2020. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
33128877 2020. Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.
33128875 2020. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
33130519 2020. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies.
33168413 2020. Associations of medications used during hospitalization and immunological changes in patients with COVID-19 during 3-month follow-up.
33035675 2020. First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
33031941 2020. Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh.
32920092 2020. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.
32896310 2020. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.
33075409 2020. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome-the superantigen hypothesis.
33064671 2020. SARS-CoV-2 specific antibody rearrangements in pre-pandemic immune repertoires of risk cohorts and COVID-19 patients.
33055417 2020. What are protective antibody responses to pandemic SARS-CoV-2?
33064340 2020. Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
33058235 2020. Background immunity: How important is it for SARS-CoV-2?
33090512 2020. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
33090493 2020. Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
33049069 2020. Analysis of SARS-CoV-2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis.
33075298 2020. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.
33073244 2020. Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
33051609 2020. Intestinal attenuation of COVID-19 inflammation.
33068416 2020. Structural analysis of SARS-CoV-2 genome and predictions of the human interactome.
33097660 2020. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
33037310 2020. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.
33033346 2020. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
33033344 2020. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
33122706 2020. Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center.
33106569 2020. The global population of SARS-CoV-2 is composed of six major subtypes.
33060796 2020. Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing.
33149224 2020. Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins.
33148089 2020. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.
33107601 2020. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
33095454 2020. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
33085084 2020. SARS-CoV-2-specific virulence factors in COVID-19.
33087872 2020. The false promise of herd immunity for COVID-19.
33181794 2020. Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Case Series Quantitative Systematic Review.
33055501 2020. COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children: A Multinational Study.
33181783 2020. Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report.
33177233 2020. In fatal COVID-19, the immune response can control the virus but kill the patient.
33033173 2020. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
33033172 2020. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.
33148390 2020. [Progress on role of cytokine storm in exacerbation of coronavirus disease 2019 (COVID-19): Review].


33029570 2020. Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions.
33047493 2020. T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic.
33064451 2020. Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry.
33087299 2020. Understanding the role of neutrophils in acute respiratory distress syndrome.
33036956 2020. Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins.
33118327 2020. Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization.
33167900 2020. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.
33167916 2020. Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran.
33142819 2020. COVID-19 and Parkinson's Disease: Shared Inflammatory Pathways Under Oxidative Stress.
33062362 2020. Discovering Associations: Kawasaki Disease and COVID-19.
33092458 2020. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment.
33115882 2020. The beneficial and pathogenic roles of complement in COVID-19.
33111059 2020. Histopathologic Findings of Coronavirus in Lung: A Mini-Review.
33091758 2020. The role of androgens in COVID-19.
33100263 2020. ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
33033152 2020. Cellular Senescence: Friend or Foe to Respiratory Viral Infections?
33060154 2020. mTORC1 Hyperactivation in LAM Leads to ACE2 Upregulation in Type II Pneumocytes: Implications for COVID-19.
33155247 2020. COVID-19 - gastrointestinal and gut microbiota-related aspects.
33193227 2020. Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals.
33193156 2020. G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2.
33193132 2020. Positive Selection of ORF1ab, ORF3a, and ORF8 Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the 2020 COVID-19 Pandemic.
33178176 2020. Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity.
33133055 2020. SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs.
33101264 2020. Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2.
33101244 2020. Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100(TM) System.
33072032 2020. Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?
33072018 2020. Translation-Associated Mutational U-Pressure in the First ORF of SARS-CoV-2 and Other Coronaviruses.
33071996 2020. Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis.
33072695 2020. The CHIR Score for Evaluating the Hyperimmune Response in COVID-19: A Preliminary Concept.
33075345 2020. The SARS-CoV-2 attachment receptor ACE2 is decreased in Crohn's disease and regulated by microbial and inflammatory signaling.
33143811 2020. Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries.
33092731 2020. Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children: A Call to Action.
33108354 2020. Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum.
33085654 2020. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.
33143379 2020. The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19.
33126723 2020. Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19.
33105634 2020. Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register.
33161369 2020. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect.
33110452 2020. Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia.
33169560 2020. Multisystem Inflammatory Syndrome in Children Related to COVID-19: the First Case in Korea.
33038012 2020. Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
33065115 2020. Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings.
33186512 2020. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study.
33043289 2020. Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein.
32988176 2020. The first case of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) in Poland, complicated by giant coronary artery aneurysms.
33160625 2020. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.
33107277 2020. An unusual inflammatory disease linked to SARS coronavirus-2 in children: are we prepared enough?
33107273 2020. Covid-19 and kawasaki disease: is there a need for revising treatment guidelines?
33031361 2020. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020.
33177214 2020. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
33036934 2020. Multisystem inflammatory syndrome in SARS-CoV-2 infection mimicking acute appendicitis in children.
33170884 2020. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
33152019 2020. Variant analysis of 1,040 SARS-CoV-2 genomes.
33112891 2020. Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2.
33181855 2020. Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
33186686 2020. Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.
33086860 2020. COVID-19 and Endocan Levels.
33115730 2020. Covid-19: Antibody prevalence in England fell from 6.0% to 4.4% over three months, study finds.
33166189 2020. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe.
33166178 2020. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children.
33105391 2020. Eosinophilic esophagitis: is the Th2 inflammation protective against the severe form of COVID-19?
33124149 2020. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
33098359 2020. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients.
33077007 2020. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.
33151142 2020. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.
33137315 2020. Coronavirus disease 2019, multisystem inflammatory syndrome in children, apolipoprotein E4, and race.
33093376 2020. COVID-19-associated Multisystem Inflammatory Syndrome in Children Presenting as Acute Pancreatitis.
33174576 2020. Context contribution to the intermolecular recognition of human ACE2-derived peptides by SARS-CoV-2 spike protein: implications for improving the peptide affinity but not altering the peptide specificity by optimizing indirect readout.
33070335 2020. The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease.
33167030 2020. Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy.
33166999 2020. Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements.
33147113 2020. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.
33181057 2020. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-gamma as a Novel Antiviral Approach Against COVID-19.


32918894 2020. Stability of severe acute respiratory syndrome coronavirus 2 RNA in placenta and fetal cells.
32866527 2020. Confirmatory evidence of the visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy.
32858014 2020. Comparative nanostructure consideration on novel coronavirus and possibility of transplacental transmission.
32853537 2020. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia.
33020692 2020. In-host Mathematical Modelling of COVID-19 in Humans.
32904415 2020. A data-driven understanding of COVID-19 dynamics using sequential genetic algorithm based probabilistic cellular automata.
32901204 2020. Analyzing COVID-19 virus based on enhanced fragmented biological Local Aligner using improved Ions Motion Optimization algorithm.
32943188 2020. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
32981683 2020. Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone.
32931703 2020. Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease.
32976572 2020. COVID-19 Knowledge Graph: a computable, multi-modal, cause-and-effect knowledge model of COVID-19 pathophysiology.
32994678 2020. Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin.
32994673 2020. CoViD-19 Susceptibility.
32923488 2020. Adaptive Evolution of Feline Coronavirus Genes Based on Selection Analysis.
32933047 2020. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
32895643 2020. Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020.
33008363 2020. Real-time audio and visual display of the Coronavirus genome.
32993540 2020. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report.
32892755 2020. Obesity, COVID-19 and innate immunometabolism.
32975865 2020. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases.
32978971 2020. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
32864374 2020. Coronavirus epitope prediction from highly conserved region of spike protein.
32920210 2020. On the genetics and immunopathogenesis of COVID-19.
32866645 2020. Interferon gamma, TGF-beta1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients.
32898238 2020. Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability.
32997739 2020. Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies.
32130405 2020. 2019 Novel Coronavirus Is Undergoing Active Recombination.
32797228 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses.
32898715 2020. The kinetics of viral load and antibodiesto SARS-CoV-2.
33005417 2020. Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32989903 2020. COVID-19 and immunological dysregulation: can autoantibodies be useful?
32983400 2020. Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity.
32983399 2020. An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19.
32894160 2020. Assessment of pulmonary surfactant in COVID-19 patients.
32988728 2020. Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
33017040 2020. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.
32979342 2020. Compartmental immunophenotyping in COVID-19 ARDS: a case series.
32895779 2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.
32944935 2020. Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids.
32897993 2020. Challenges in Diagnosing Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in a Child With Severe Neurocognitive Impairment and Social Isolation.
32814701 2020. The Urgency of Conducting Serological Studies for COVID-19.
32788194 2020. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
33024281 2020. Cross-reactive memory T cells and herd immunity to SARS-CoV-2.
32943538 2020. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
32989130 2020. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
32963094 2020. Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
32964627 2020. Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review.
32946131 2020. Investigation of immune cells on elimination of pulmonary-Infected COVID-19 and important role of innate immunity, phagocytes.
32928234 2020. Characterization of codon usage pattern in SARS-CoV-2.
33011520 2020. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
32979477 2020. Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
32918944 2020. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
33003587 2020. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.
32992592 2020. Host Immune Response Driving SARS-CoV-2 Evolution.
32971895 2020. Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus.
32967229 2020. Immune Checkpoints in Viral Infections.
32961897 2020. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
32937868 2020. Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.
32929876 2020. The Longitudinal Immune Response to Coronavirus Disease 2019: Ch<iframe src="http://www.kidney.de/amapp.php?a=g the Cytokine Storm.
32964796 2020. Coronavirus interactions with the cellular autophagy machinery.
32975439 2020. Cardiac Findings in Pediatric Patients With Multisystem Inflammatory Syndrome in Children Associated With COVID-19.
32912123 2020. Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts' Cell.
33019935 2020. COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?
33016156 2020. Hypothesis: The electrical properties of coronavirus.
32914439 2020. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design.
32972235 2020. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
32990479 2020. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
32986664 2020. COVID-19: Significance of antibodies.
32981399 2020. COVID-19 Infection: Concise Review Based on the Immunological Perspective.
33010854 2020. COVID-19-Related Multisystem Inflammatory Syndrome in Children Affects Left Ventricular Function and Global Strain Compared with Kawasaki Disease.
33023287 2020. COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?
32945158 2020. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
33016027 2020. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
32948117 2020. Household pets and SARS-CoV2 transmissibility in the light of the ACE2 intrinsic disorder status.
32901940 2020. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.
32926425 2020. Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.
33022076 2020. Immunobiology and immunotherapy of COVID-19: A clinically updated overview.
32962383 2020. Mathematical modeling and cellular automata simulation of infectious disease dynamics: Applications to the understanding of herd immunity.
32910875 2020. Is 'inflammaging' fuelling severe COVID-19 disease?
32817223 2020. Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins.
32880615 2020. Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions.
32840583 2020. Difficult to Determine Herd Immunity Threshold for COVID-19.
32808969 2020. Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers.
32795406 2020. Pseudotumor cerebri syndrome associated with MIS-C: a case report.
32960167 2020. Immunite adaptative contre le virus SARS-CoV-2.
32905684 2020. Trained Innate Immunity, Epigenetics, and Covid-19.
32966713 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
32966712 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32966711 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32966710 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32999467 2020. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
32788748 2020. Single-cell landscape of immunological responses in patients with COVID-19.
32855555 2020. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.
32895541 2020. T cells in COVID-19 - united in diversity.
32887977 2020. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
32929268 2020. Seasonal coronavirus protective immunity is short-lasting.
32382153 2020. Protecting the population with immune individuals.
32812012 2020. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
32908214 2020. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
32690955 2020. Inhibition of the integrated stress response by viral proteins that block p-eIF2-eIF2B association.
32788708 2020. The type I interferon response in COVID-19: implications for treatment.
32908316 2020. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.
32906143 2020. The coding capacity of SARS-CoV-2.
32942285 2020. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.
32901123 2020. The coronavirus is mutating - does it matter?
32895961 2020. Neuropathological findings in two patients with fatal COVID-19.
32935873 2020. Invited Review: The spectrum of neuropathology in COVID-19.
32981462 2020. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.
32925824 2020. Bronchopulmonary MDR protein expression may protect against COVID-19 infection.
32932334 2020. Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report.
33021596 2020. Serum Responses of Children With Kawasaki Disease Against Severe Acute Respiratory Syndrome Coronavirus 2 Proteins.
32994342 2020. Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity.


32997488 2020. Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor.
32946224 2020. Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain.
32934769 2020. Striking Similarities between CDRs in Some mAbs That Neutralize COVID-19.
33006576 2020. Room-temperature neutron and X-ray data collection of 3CL M(pro) from SARS-CoV-2.
33020343 2020. The Management of Cytokine Storm in COVID-19.
32895623 2020. Crystal structure of SARS-CoV-2 papain-like protease.
32962761 2020. Severe COVID-19: what have we learned with the immunopathogenesis?
32991323 2020. SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime.
33006233 2020. COVID-19 is an emergent disease of aging.
32955770 2020. Cellular senescence as a potential mediator of COVID-19 severity in the elderly.
32956495 2020. Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19.
32965717 2020. SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?
32978876 2020. Transmission-dynamics models for the SARS Coronavirus-2.
32838273 2020. Detection of severe acute respiratory syndrome coronavirus 2 in placentas with pathology and vertical transmission.
32996784 2020. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?
32851969 2020. Identification of Exertional Hypoxia and Its Implications in SARS-CoV-2 Pneumonia.
32925314 2020. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.
32925313 2020. Human Leukocyte Antigen-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.
32968798 2020. Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade.
32914167 2020. Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.
32966582 2020. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
32966547 2020. Hypertension and SARS-CoV-2 infection: is inflammation the missing link?
32966765 2020. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
32841599 2020. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.
32946786 2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32810439 2020. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
32810438 2020. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
32783916 2020. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.
33010815 2020. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
32991844 2020. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
32991843 2020. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
32970989 2020. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
32991842 2020. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
32979941 2020. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
32979319 2020. Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
32976799 2020. COVID-19 Makes B Cells Forget, but T Cells Remember.
32877699 2020. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
33020722 2020. Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2.
32983570 2020. Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019.
32953130 2020. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2.
32941787 2020. Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2.
32841605 2020. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.
32877692 2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.
32810597 2020. Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.
32917983 2020. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
32895485 2020. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients.
32879471 2020. Expansion of atypical memory B cells is a prominent feature of COVID-19.
32963357 2020. Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients.
32966801 2020. Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy.
32946807 2020. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.
32941788 2020. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.
32979938 2020. Evasion of Type I Interferon by SARS-CoV-2.
32904468 2020. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients.
32839763 2020. SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential.
33015650 2020. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.
32835306 2020. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
32838342 2020. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19.
32861744 2020. The multifaceted role of plasminogen in inflammation.
32916095 2020. Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks.
32911691 2020. Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection.
33003471 2020. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness.
32859121 2020. SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.
32854433 2020. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.
32847031 2020. A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection?
32750325 2020. Chemical kinetics of the development of coronaviral infection in the human body: Critical conditions, toxicity mechanisms, "thermoheliox", and "thermovaccination".
32971122 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
32986926 2020. Binding of SARS-CoV-2 to cell receptors: a tale of molecular evolution.
32910974 2020. COVID-19 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units.
32931823 2020. Etoposide as Salvage Therapy for Cytokine Storm Due to COVID-19.
32221133 2020. Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from different stages.
32938299 2020. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.
32897389 2020. Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
32901577 2020. Ribonucleocapsid assembly/packaging signals in the genomes of the coronaviruses SARS-CoV and SARS-CoV-2: detection, comparison and implications for therapeutic targeting.
33000143 2020. Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection.
32941618 2020. A Granulocytic Signature Identifies COVID-19 and Its Severity.
32986250 2020. A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB101 with COVID-19 fatality in Mexican population: An ecological approach.
32975856 2020. Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: Emerged haplotypes and informative Tag nucleotide variations.
32970329 2020. Genomic and proteomic mutation landscapes of SARS-CoV-2.
32966656 2020. Biochemical rationale for hypoalbuminemia in COVID-19 patients.
32966646 2020. Phylogenetic analysis of SARS-CoV-2 in the first few months since its emergence.
32966614 2020. Clinical value anti-SARS-COV-2 serum IgA titration in patients with COVID-19.
33006900 2020. Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins.
32786692 2020. Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes.
32786691 2020. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level.
32937590 2020. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
32985562 2020. Immune dysfunction following COVID-19, especially in severe patients.
32929138 2020. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.
33020502 2020. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals.
32979900 2020. The assessment of the serum levels of TWEAK and prostaglandin F2? in COVID - 19.
32921745 2020. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
32921728 2020. The "perfect" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic.
32921739 2020. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma.
32914749 2020. Revisiting Clinical Autopsies: Lessons to be Taken from the COVID-19 Pandemic.
32985209 2020. Genomic characterization and phylogenetic evolution of the SARS-CoV-2.
33010181 2020. Maximizing the value of human biospecimens: Lessons from coronavirus and the Seattle flu study.
32997945 2020. Biological Mechanisms of COVID-19 ARDS.
32997512 2020. Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intra-pulmonary Shunts in Response to Microvascular Occlusion.
32997507 2020. Reply to: Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intra-pulmonary Shunts in Response to Microvascular Occlusion.
32826529 2020. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
32996443 2020. Is Higher Viral Load in SARS-CoV-2 Associated with Death?
32897891 2020. Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children.
33006605 2020. Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity.
32941261 2020. Myocarditis in Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019.
33020822 2020. Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19.
32902889 2020. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
32897566 2020. Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
32897544 2020. Immune response against SARS-CoV-2 in pediatric patients including young infants.
32910461 2020. The dynamics of immune response in COVID-19 patients with different illness severity.
32910458 2020. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
33009829 2020. The antibody response to the glycan alpha-Gal correlates with COVID-19 disease symptoms.
32940328 2020. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.


32894217 2020. Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset.
32930052 2020. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.
33008679 2020. inverted question markInfeccion por SARS-CoV-2 como desencadenante de un sindrome inflamatorio sistemico?
32904601 2020. Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications.
32959075 2020. Paediatric multisystem inflammatory syndrome associated with COVID-19: filling the gap between myocarditis and Kawasaki?
32949577 2020. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.
32974353 2020. SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage.
32850499 2020. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.
33013929 2020. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
32983176 2020. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.
32983174 2020. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
32983172 2020. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in".
32983157 2020. The Metabolic Changes and Immune Profiles in Patients With COVID-19.
32983152 2020. The Immune Response and Immunopathology of COVID-19.
32983141 2020. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
32983106 2020. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.
32973803 2020. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
32922406 2020. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
33013759 2020. Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature.
32973730 2020. The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle.
32974389 2020. SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle.
33013423 2020. Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis.
32982760 2020. Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2.
32922297 2020. COVID-19 Usurps Host Regulatory Networks.
32943587 2020. Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic.
32895641 2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
33015593 2020. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.
33015591 2020. PPARgamma Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.
32989429 2020. SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.
32939273 2020. Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.
32916324 2020. IFN-gamma receptor 2 deficiency initial mimicry of multisystem inflammatory syndrome in children (MIS-C).
32990278 2020. Antibody responses in COVID-19 patients.
32975374 2020. Naturally activated adaptive immunity in COVID-19 patients.
32949179 2020. STAT3 isoforms differentially affect ACE2 expression: A potential target for COVID-19 therapy.
32924263 2020. Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis.
32966269 2020. Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2.
33021506 2020. COVID-19 and myeloid cells: complex interplay correlates with lung severity.
32976117 2020. Are T cells helpful for COVID-19: the relationship between response and risk.
32957548 2020. Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19.
32989935 2020. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.
32929291 2021. Structural dynamics of COVID-19 main protease.
32930936 2020. Infectivity of SARS-CoV-2: there Is Something More than D614G?
32885971 2020. The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein.
32847856 2020. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.
33015645 2020. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.
33015644 2020. Defining the scourge of COVID-19 hyperinflammatory syndrome.
32978313 2020. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
32978311 2020. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
32948688 2020. Impaired Cytotoxic CD8(+) T Cell Response in Elderly COVID-19 Patients.
32913009 2020. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
32899009 2020. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
32997001 2020. Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil.
32916246 2020. Immune response in COVID-19: What do we currently know?
32911086 2020. Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses.
32891874 2020. Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis.
32972948 2020. Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020.
32972934 2020. Coding-Complete Genome Sequences of Three SARS-CoV-2 Strains from Bangladesh.
33019592 2020. Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.
32895815 2020. COVID-19-Spatfolge bei Kindern: Multisystemische Entzundung : Coronavirus-Pandemie.
32790663 2020. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020.
32888056 2020. GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes.
32993497 2020. The role of host defences in Covid 19 and treatments thereof.
32945643 2020. SeXX and COVID-19: tussle between the two.
32938700 2020. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
32871063 2020. Humoral Immune Response to SARS-CoV-2 in Iceland.
32948854 2020. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19.
32943637 2020. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.
32943630 2020. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
32917884 2020. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.
32908300 2020. COVID-19 herd immunity: where are we?
33009506 2020. Fatty monocytes in COVID-19.
32895513 2020. Coordinated and sustained immune memory responses after mild COVID-19.
32895512 2020. SARS-CoV-2 ORF9c: a mysterious membrane-anchored protein that regulates immune evasion?
32895511 2020. Does a host restriction factor facilitate entry of SARS-CoV-2?
32995660 2020. Single cell sequencing unraveling genetic basis of shared immunologic switch between Severe COVID19 and Obesity.
32984641 2020. Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity.
32939324 2020. Immune responses during COVID-19 infection.
32961074 2020. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.
32898469 2020. SARS-CoV-2 envelope protein topology in eukaryotic membranes.
32999893 2020. Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19.
32989419 2020. The Antibody Response to SARS-CoV-2 Infection.
32792288 2020. Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19.
32891582 2020. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation.
32901164 2020. Apparent scaling of virus surface roughness-An example from the pandemic SARS-nCoV.
32911234 2020. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection.
32997660 2020. IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
32941419 2020. Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization.
33006981 2020. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
32976531 2020. The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.
32970753 2020. A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity.
32936826 2020. Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
32903266 2020. Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma.
32913364 2020. A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.
32894404 2020. The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis.
32965372 2020. Kawasaki and COVID-19 disease in children: a systematic review.
32936318 2020. Kawasaki-like disease in children with COVID-19.
32895366 2020. Storm of soluble immune checkpoints associated with disease severity of COVID-19.
32929061 2020. Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients.
33024093 2020. SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity.
33024073 2020. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling.
32984664 2020. Identification of Geographic Specific SARS-Cov-2 Mutations by Random Forest Classification and Variable Selection Methods.
32920296 2020. Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease.
32815359 2020. Rettelse: Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn.
32904637 2020. The role of carbon monoxide and heme oxygenase-1 in COVID-19.
32954666 2020. Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline.
32953471 2020. Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer.
32923679 2020. C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis.
33024515 2020. Immunological aspects of COVID-19: What do we know?
32917722 2020. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
32922564 2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.
32796063 2020. Neuronal Ablation of Alpha/Beta Interferon (IFN-alpha/beta) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-gamma Responsiveness in Microglia/Macrophages.
32938761 2020. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.


32934770 2020. Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity.
32952147 2020. Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.
32919977 2020. Immunopathology of Hyperinflammation in COVID-19.
32876012 2020. Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study.
32950319 2020. Bell's palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32992681 2020. Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis.
32954242 2020. Host tolerance contributes to persistent viral shedding in COVID-19.
32923992 2020. Multisystem inflammatory syndrome in children: A systematic review.
32984786 2020. The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study.
33001029 2020. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.
32983015 2020. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses.
32984206 2020. Pediatric Inflammatory Multisystem Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics.
32974046 2020. Toll-like receptors and COVID-19: a two-faced story with an exciting ending.
33005212 2020. In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome.
33015411 2020. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.
32954047 2020. Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries.
33007398 2020. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.
32966857 2020. Mutations on COVID-19 diagnostic targets.
32927009 2020. Molecular phylogeny and missense mutations of envelope proteins across coronaviruses.
32920121 2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.
33017875 2020. Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population.
33017874 2020. Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA.
32902818 2020. A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.
32983837 2020. Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays.
32984566 2020. Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction.
32904785 2020. Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates.
32984567 2020. A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.
32904861 2020. Antibody response to SARS-Co-V-2, diagnostic and therapeutic implications.
32950268 2020. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
32953455 2020. A challenging case of multisystem inflammatory syndrome in children related to coronavirus Disease-19 hospitalized under adult medical service.
33007369 2020. "Cytokine storm", not only in COVID-19 patients. Mini-review.
33007368 2020. How NETosis could drive "Post-COVID-19 syndrome" among survivors.
32989677 2020. Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
32930973 2020. Multisystem Inflammatory Syndrome in Children Associated with COVID 19 Treated with Oral Steroid.
32950697 2020. Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.
33014208 2020. How COVID-19 induces cytokine storm with high mortality.
33002623 2020. Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation.
32920233 2020. Antibody-dependent enhancement of coronavirus.
32920235 2020. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome.
32945352 2020. Transcriptomic analysis of COVID19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.
32993015 2020. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
32933166 2020. Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as "Achilles' Heel" of Viruses Contributing to Anti-Viral Immune Protection.
32917729 2020. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients.
32997749 2020. Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.
33011038 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature.
32954708 2020. Analysis of Host Cell Receptor GRP78 for Potential Natural Reservoirs of SARS-CoV-2.
32970885 2020. Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19.
32956726 2020. Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.
32920062 2020. A possible role for GRP78 in cross vaccination against COVID-19.
32853600 2020. Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR.
32853599 2020. COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
32853597 2020. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.
32910175 2020. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
32919931 2020. Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children.
32982366 2020. Role of IFN and Complements System: Innate Immunity in SARS-CoV-2.
32991738 2020. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.
32979386 2020. Use of tocilizumab in multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2.
32946801 2020. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view.
32945863 2020. Pediatric Inflammatory Multisystem Syndrome: Time to Collaborate.
32951037 2020. Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients.
32919067 2020. A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2.
32967693 2020. A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual.
32938769 2020. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.
32937615 2020. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
32972123 2020. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.
32956615 2020. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.
32835654 2020. Multisystem inflammatory syndrome in children in South Africa.
32979317 2020. The complexities of SARS-CoV-2 serology.
32987502 2020. The within-host viral kinetics of SARS-CoV-2.
32944295 2020. Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.
2972994 1988. Sequence specificity of streptozotocin-induced mutations.
32958678 2020. Low genetic diversity may be an Achilles heel of SARS-CoV-2.
32956843 2021. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.
32965173 2020. Secondary structure of the SARS-CoV-2 5'-UTR.
32991014 2020. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
33024223 2020. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
33024213 2020. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
32963115 2020. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.
32972818 2020. COVID-19 and Metabolic Syndrome: NF-kappaB Activation. Crossroads.
32921279 2020. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
32921711 2020. An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise?
32969849 2020. Atypical Endovascular Cells in SARS-CoV-2 Pneumonia.
32915505 2020. Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins.
32907802 2020. Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al.
32907800 2020. Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al.
32978236 2020. Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al.
32958511 2020. Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'.
32958508 2020. Correspondence to 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'.
32933921 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): what does the future hold?
32943427 2020. Covid-19: Do many people have pre-existing immunity?
32920919 2020. Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection?
32902374 2020. Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses.
32902372 2020. Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus.
32985922 2020. Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection.
32826281 2020. Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.
32978281 2020. Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
32958687 2020. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
32930458 2020. Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+) /CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2.
32930456 2020. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
32918747 2020. Ultrastructure of cell trafficking pathways and coronavirus: how to recognise the wolf amongst the sheep.
32969960 2020. Features of Intestinal Disease Associated with COVID-Related Multisystem Inflammatory Syndrome in Children.
32924059 2020. The Natural History of SARS-Cov-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review.
31743644 2019. Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide.
32989174 2020. MAIT cell activation and dynamics associated with COVID-19 disease severity.
32943497 2020. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.
32994211 2020. High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design.
32958614 2020. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.
32994364 2020. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.
32958581 2020. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
32972996 2020. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
32972995 2020. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
32958580 2020. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.


32881367 2020. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
32912866 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): the Evelina Experience.
32933913 2020. Paediatric case of prolonged COVID-19 manifesting as PMIS-TS and atypical Kawasaki.
32943758 2020. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
32966752 2020. Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation.
32935083 2020. Management of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Survey from the International Kawasaki Disease Registry.
32967859 2020. The pulmonary pathology of COVID-19.
32948868 2020. SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19.
32927483 2020. Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity.
32907819 2020. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names.
33020707 2020. Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase.
32977223 2020. Immunological features of coronavirus disease 2019 in patients with cancer.
33022277 2020. ACE2-containing extracellular vesicles and exomeres bind the SARS-CoV-2 spike protein.
33025514 2020. Low-Dose Dexamethasone Following IVIG in Pediatric Inflammatory Multisystem Syndrome in Temporal Association with COVID-19 (PIMS-TC).
32986832 2020. Biased mutation and selection in RNA viruses.
32941612 2020. Potential pathogenicity determinants identified from structural proteomics of SARS-CoV and SARS-CoV-2.
33000221 2020. Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19.
32995557 2020. Integrated genomic view of SARS-CoV-2 in India.
32976188 2020. High level of defensin alpha 5 in intestine may explain the low incidence of diarrhoea in COVID-19 patients.
32910469 2020. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
32935333 2020. T-cell responses and therapies against SARS-CoV-2 infection.
33001920 2020. Light and corona: guided-wave readout for coronavirus spike protein-host-receptor binding.
33009246 2020. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia.
32979740 2020. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.
32897642 2020. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
33003176 2020. Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children's Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up.
32970023 2020. Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 Pandemic.
32925543 2020. Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19.
32947601 2020. Multisystem Inflammatory Syndrome (MIS-C) Surveillance and COVID-19 in Latin America.
32925547 2020. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection.
32898090 2020. MIS-C After ARDS Associated With SARS-CoV-2.
32907921 2020. SARS-CoV-2 Polymorphisms and Multisystem Inflammatory Syndrome in Children.
32973121 2020. Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 Serology.


32776378 2020. Beyond serosurveys: Human biology and the measurement of SARS-Cov-2 antibodies.
32459509 2020. Breaking Circular Thinking about the Value of Oxygenation.
32459507 2020. Reply to Modesto-Alapont et al.: Breaking Circular Thinking about the Value of Oxygenation.
32860089 2020. High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19.
32745829 2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.
32721790 2020. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics.
32818817 2020. Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain.
32866437 2020. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.
32889638 2020. Coronaviruses and stress: from cellular to global.
32777699 2020. SARS-CoV-2 IgG antibody responses in New York City.
32799894 2020. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge.
32752129 2020. Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.
32784826 2020. Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression.
32844713 2020. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.
32882706 2020. COVID-19 is, in the end, an endothelial disease.
32882708 2020. How does COVID-19 kill at home and what should we do about it?
32887992 2020. Multisystem inflammatory syndrome in an adult with SARS-CoV-2 infection.
32859681 2020. Endothelial to mesenchymal transition (EndMT): a precursor to post-SARS-CoV-2 infection (COVID-19) interstitial pulmonary fibrosis and vascular obliteration?
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
32881045 2020. COVID-19 related lung pathology: old patterns in new clothing?
32888767 2020. Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance.
32773417 2020. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis.
32837525 2020. Role of Damage-Associated Molecular Patterns in Light of Modern Environmental Research: A Tautological Approach.
32767018 2020. Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.
32851474 2020. Postmortem examination of three SARS-CoV-2-positive autopsies including histopathologic and immunohistochemical analysis.
32861838 2020. Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection.
32853638 2020. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1.
32864865 2020. The phenotypic changes of gammadelta T cells in COVID-19 patients.
32786709 2020. Computational Prediction of Mutational Effects on SARS-CoV-2 Binding by Relative Free Energy Calculations.
32827284 2020. Unraveling the Immune Response in Severe COVID-19.
32829467 2020. Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
32870815 2020. Immune pathogenesis of COVID-19-related Multisystem Inflammatory Syndrome in Children (MIS-C).
32730233 2020. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
32730226 2020. Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?
32764200 2020. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
32759504 2020. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
32841212 2020. Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals.
32833687 2020. SARS-CoV-2 specific T-cell responses and correlations with COVID-19 patient predisposition.
32784290 2020. COVID-19 severity associates with pulmonary redistribution of CD1c+ DC and inflammatory transitional and nonclassical monocytes.
32531971 2020. Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients.
32826322 2020. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate.
32763812 2020. The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong.
32818852 2020. SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.
32850082 2020. COVID-19 infection and its deadly cytokine storm in a young obese adult.
32779780 2020. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.
32773261 2020. SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem.
32887634 2020. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
32243948 2020. Respiratory mucus and persistence of virus on surfaces.
32727811 2020. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
32726448 2020. Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
32726417 2020. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
31621854 2020. Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
32726446 2020. Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
32745172 2020. Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques.
32812049 2020. Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
32785649 2020. COVID 19 Vaccines: Should we fear ADE?
32738141 2020. Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients.
31610541 2020. Innate Immune Evasion by Human Respiratory RNA Viruses.
32736274 2020. Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function?
32794348 2020. Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.
32779742 2020. A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease?
32761905 2020. Comment on Hu et al: The cytokine storm and COVID-19.
32779784 2020. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
32717049 2020. Cytoskeleton-a crucial key in host cell for coronavirus infection.
32771409 2020. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus.
32818486 2020. Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes.
32870373 2020. Why do SARS-CoV-2 NSPs rush to the ER?
32826022 2020. Kawasaki-like disease among Italian children in the COVID-19 era.
32768467 2020. Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function following Multisystem Inflammatory Syndrome in Children.
32768466 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review.
32756980 2020. Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report.
32828177 2020. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome.
32791052 2020. Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan.
32791050 2020. Coronial autopsies identify the indirect effects of COVID-19.
32813814 2020. Low risk of serological cross-reactivity between dengue and COVID-19.
32872641 2020. Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.
32835005 2020. Methods for making multiple alignment of genomic sequences for severe acute respiratory syndrome coronavirus 2.
32839745 2020. miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East.
32847471 2020. Vascular underpinning of COVID-19.
32750256 2020. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester.
32756606 2020. Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain.
32726325 2020. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.
32787702 2020. Anterior Pulmonary Ventilation Abnormalities in COVID-19.
32810737 2020. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients.
32738789 2020. Nox2 activation in Covid-19.
32853309 2020. Sindrome inflamatorio multisistemico asociado a COVID-19 en ninos y adolescentes: un llamado al diagnostico.
32845568 2020. Interleukin-6 in Covid-19: A systematic review and meta-analysis.
32844538 2020. Alpha-1-antitrypsin: A possible host protective factor against Covid-19.
32883951 2020. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.
32883949 2020. Profiling and characterization of SARS-CoV-2 mutants' infectivity and antigenicity.
32879307 2020. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
32815352 2020. Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn.
32854725 2020. Characterization of accessory genes in coronavirus genomes.
32755175 2020. CT Manifestations of Coronavirus Disease (COVID-19) Pneumonia and Influenza Virus Pneumonia: A Comparative Study.
32720486 2020. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.
32872802 2020. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.
32755395 2020. MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.
32787714 2020. The Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-like Syndrome in Adults: Overlapping Manifestations of COVID-19.
32885825 2020. Specialized pro-resolving mediator network: an update on production and actions.
32723457 2020. Silent Hypoxia in COVID-19: What is Old is New Again!
32826724 2020. Multisystem Inflammatory Syndrome Associated With Coronavirus Disease in Children: A Multi-centered Study in Belem, Para, Brazil.
32677813 2020. Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19.
32639461 2020. Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection.
32833376 2020. Mutation dans la proteine Spike de SARS-CoV-2.
32615049 2020. The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.
32788292 2020. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
32753553 2020. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
32763915 2020. A molecular pore spans the double membrane of the coronavirus replication organelle.
32675355 2020. The pandemic virus is slowly mutating. But does it matter?
32753554 2020. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.
32855215 2020. MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.
32817270 2020. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges.


32840109 2020. iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2.
32765942 2020. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.
32765940 2020. Decreased Naive T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.
32790652 2020. Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2.
32876680 2020. Forty Postmortem Examinations in COVID-19 Patients.
32776556 2020. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients.
32811513 2020. The current landscape of coronavirus-host protein-protein interactions.
32864628 2020. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.
32864626 2020. Delving beneath the surface of hyperinflammation in COVID-19.
32838362 2020. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
32778426 2020. Reacciones cruzadas entre factor reumatoide e IgM SARS-CoV-2.
32838292 2020. Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19).
32759017 2020. The importance of cell-mediated immunity in COVID-19 - An opinion.
32758906 2020. Are night shift workers at an increased risk for COVID-19?
32795830 2020. Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19.
32721809 2020. Kawasaki-like disease in children with COVID-19: A hypothesis.
32795834 2020. IL-17A and TNF-alpha as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.
32724296 2020. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.
32769902 2020. Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report.
32808941 2020. Hypermetabolism in critically ill patients with COVID-19 and the effects of hypothermia: A case series.
31883098 2020. Histopathologic Evaluation and Scoring of Viral Lung Infection.
31883097 2020. Evaluation of Activation and Inflammatory Activity of Myeloid Cells During Pathogenic Human Coronavirus Infection.
32732237 2020. Genome Sequences of SARS-CoV-2 Strains Detected in Hong Kong.
32732236 2020. Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh.
32732235 2020. SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology.
32763945 2020. Genome Sequences of Six SARS-CoV-2 Strains Isolated in Morocco, Obtained Using Oxford Nanopore MinION Technology.
32855259 2020. Four SARS-CoV-2 Genome Sequences from Late April in Stockholm, Sweden, Reveal a Rare Mutation in the Spike Protein.
32791568 2020. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection.
32858978 2020. Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis.
32879413 2020. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.
32741970 2020. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.
32792598 2020. Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data.
32802902 2020. Genome-wide computational prediction of miRNAs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed target genes involved in pulmonary vasculature and antiviral innate immunity.
32788344 2020. Serum protein profiling reveals a landscape of inflammation and immune signaling in early-stage COVID-19 infection.
32744436 2020. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
32817460 2020. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.
32873611 2020. Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19.
32733001 2020. Activation and evasion of type I interferon responses by SARS-CoV-2.
32764693 2020. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells.
32764665 2020. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.
32737462 2020. IgGs drive COVID-19 myeloid hyperinflammation.
32732951 2020. NK cells in COVID-19: protectors or opponents?
32728222 2020. T cell responses in patients with COVID-19.
32728221 2020. Tissue damage from neutrophil-induced oxidative stress in COVID-19.
32873888 2020. Long-lasting SARS-CoV-2-specific T cell memories.
32873886 2020. Immune correlates of SARS-CoV-2 protection.
32839569 2020. Not just antibodies: B cells and T cells mediate immunity to COVID-19.
32826976 2020. CD8(+) T cells remember same bits of SARS-CoV-2.
32826975 2020. Attacking the defence: SARS-CoV-2 can infect immune cells.
32826974 2020. Altered immune cell differentiation in the lungs of patients with critical COVID-19.
32807862 2020. Shared CD8(+) T cell receptors for SARS-CoV-2.
32807861 2020. Spatial resolution of SARS-CoV-2 lung infection.
32782358 2020. The role of IgG Fc receptors in antibody-dependent enhancement.
32782355 2020. Getting to the (germinal) centre of SARS-CoV-2.
32782353 2020. Antibody response to SARS-CoV-2 - sustained after all?
32835124 2020. A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection.
32855992 2020. A Case of Steroid-Responsive, COVID-19 Immune Reconstitution Inflammatory Syndrome Following the Use of Granulocyte Colony-Stimulating Factor.
32879797 2020. Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp.
32742818 2020. RdRp mutations are associated with SARS-CoV-2 genome evolution.
32742815 2020. Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.
32722596 2020. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
32721181 2020. Immunometabolic Status of COVID-19 Cancer Patients.
32881907 2020. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
32857808 2020. SNPs or RNA modifications? Concerns on mutation-based evolutionary studies of SARS-CoV-2.
32726355 2020. Interplay between SARS-CoV-2 and the type I interferon response.
32845937 2020. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020.
32822426 2020. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.
32797103 2020. Footprint of the host restriction factors APOBEC3 on the genome of human viruses.
32785209 2020. Molecular epidemiology of SARS CoV-2: a review of current data on genetic variability of the virus.
32844302 2020. The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review.
32727465 2020. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
32723327 2020. The pathophysiology of 'happy' hypoxemia in COVID-19.
32880863 2020. Structure of SARS-CoV-2 main protease in the apo state.
32161317 2020. A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA.
32848162 2020. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
32843695 2020. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.
32820179 2020. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide.
32814791 2020. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
32669297 2020. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
32694201 2020. Distinct conformational states of SARS-CoV-2 spike protein.
32703906 2020. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
32661059 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
32661058 2020. Structural basis of a shared antibody response to SARS-CoV-2.
32728018 2020. Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.
32712629 2020. COVID-19: immunopathogenesis and Immunotherapeutics.
32868756 2020. Immune characteristics of severe and critical COVID-19 patients.
32843617 2020. Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2.
32796814 2020. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
32879905 2020. Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients.
32684101 2020. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
32424954 2020. The hypothetical role of phosphatidic acid in subverting ER membranes during SARS-CoV infection.
32701194 2020. Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia.
32863136 2020. Does Cross-neutralization of SARS-CoV-2 Only Relate to High Pathogenic Coronaviruses?
32863134 2020. Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
32863133 2020. Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2.
32863132 2020. Is Immunological Memory a Burden in Times of COVID-19?
32720214 2020. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
32705575 2020. Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity.
32822061 2020. Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection.
31505321 2019. Coronavirus genomic RNA packaging.
32717345 2020. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
32730781 2020. Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
32771430 2020. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
32825063 2020. The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV.
32824272 2020. A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture.
32787398 2020. Coronavirus-19 and malaria: The great mimics.
32734595 2020. Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.
32881583 2020. The Respiratory Drive: An Overlooked Tile of COVID-19 Pathophysiology.
32833500 2020. Injury to the Endothelial Glycocalyx in Critically Ill COVID-19 Patients.
32822239 2020. Bubble Trouble in COVID-19.
32813543 2020. On Happy Hypoxia and on Sadly Ignored "Acute Vascular Distress Syndrome" in COVID-19 Patients.


32761524 2020. Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?
32805179 2020. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
32805177 2020. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
32854247 2020. The Importance of Redox Status in the Frame of Lifestyle Approaches and the Genetics of the Lung Innate Immune Molecules, SP-A1 and SP-A2, on Differential Outcomes of COVID-19 Infection.
32735900 2020. Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses.
31705922 2020. Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice.
31634494 2020. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
32749662 2020. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
32761270 2020. Detection of SARS-CoV-2 by RNAscope((R)) in situ hybridization and immunohistochemistry techniques.
32737584 2020. A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
32719955 2020. The antiviral protein viperin interacts with the viral N protein to inhibit proliferation of porcine epidemic diarrhea virus.
32884212 2020. Comments on "An insertion unique to SARS-CoV-2 exhibits super antigenic character strengthened by recent mutations" by Cheng MH et al.2020.
32831521 2020. Putative Natural History of CoViD-19.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
32728349 2020. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients.
32882823 2020. Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2.
32861070 2020. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
32803496 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b.
32770392 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of the nucleic acid-binding domain of SARS-CoV-2 non-structural protein 3e.
32825713 2020. Caveolae and Lipid Rafts in Endothelium: Valuable Organelles for Multiple Functions.
32752270 2020. Viral Ubiquitin and Ubiquitin-Like Deconjugases-Swiss Army Knives for Infection.
32829962 2020. The looming storm: Blood and cytokines in COVID-19.
32803145 2020. Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19.
32750108 2020. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
32707576 2020. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
32733733 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection.
32723436 2020. COVID-19: disCOVering the role of complement system.
32820801 2020. Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.
32749472 2020. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
32883529 2020. Coronavirus 2019, Microthromboses, and Platelet Activating Factor.
32742654 2020. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.
32771962 2020. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
32859264 2020. Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies.
32854750 2020. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
32742881 2020. Pediatric Case of Severe COVID-19 With Shock and Multisystem Inflammation.
32775080 2020. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
32864262 2020. A Review of Postmortem Findings in Patients With COVID-19.
32884871 2020. COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?
32852642 2020. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses.
32767259 2020. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients.
32838054 2021. Subcellular hot spots of GPCR signaling promote vascular inflammation.
32784125 2020. Natural killer cell responses to emerging viruses of zoonotic origin.
32866898 2020. ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis.
32873506 2020. Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-19.
32864402 2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
32861199 2020. Monocyte activation in systemic Covid-19 infection: Assay and rationale.
32818801 2020. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta.
32815517 2020. 3D virtual pathohistology of lung tissue from Covid-19 patients based on phase contrast X-ray tomography.
32752979 2020. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
32691695 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
32880939 2020. Telomere length, epidemiology and pathogenesis of severe COVID-19.
32869220 2020. COVID-19 and the Antiviral Effect of Saliva.
32816244 2020. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis.
32803422 2020. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach.
32718910 2020. Extensive coronary artery thrombosis complicating COVID-19 infection and haemophagocytic lymphohistiocytosis.
32733388 2020. Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine?
32849840 2020. Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations.
32765596 2020. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein.
32765592 2020. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
32849666 2020. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
32849654 2020. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
32849650 2020. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
32849648 2020. Mucosal-Associated Invariant T Cells as a Possible Target to Suppress Secondary Infections at COVID-19.
32886791 2020. Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain.
32883919 2020. Recent developments in COVID-19 therapeutics & current evidence for COVID-19-associated multisystem inflammatory syndrome.
32859866 2020. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
32890939 2020. COVID-19: Brief check through the pathologist's eye (autopsy archive).
32888706 2020. SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings.
32826334 2020. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
32826331 2020. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
32890979 2020. Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity.
32759262 2020. Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al.
32759260 2020. Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future.
32866279 2020. Haemoglobin oxygen affinity in patients with severe COVID-19 infection: Still unclear.
32826650 2020. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
32833696 2020. Does Severe Acute Respiratory Syndrome Coronavirus 2 Cause Sepsis?
32749095 2020. MAIT Cells in COVID-19: Heroes, Villains, or Both?
32749094 2020. Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.
32881654 2020. Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19.
32633334 2020. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43.
32750889 2020. AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells.
32864784 2020. Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2.
32762417 2020. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.
32752936 2020. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19.
32746720 2020. Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods.
32851910 2020. Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding.
32773643 2020. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32860278 2020. Associations between serum amyloid A, interleukin-6, and COVID-19: A cross-sectional study.
32769685 2020. Immunity, inflammation and the vasculature in the COVID-19 era.
32887754 2020. Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
32878912 2020. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
32744884 2020. Letter to the Editor: COVID-19, Mitochondria, and Interferon.
32721252 2020. Eosinophil-Derived Neurotoxin and Respiratory Tract Infection and Inflammation: Implications for COVID-19 Management.
32729633 2020. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
32881026 2020. Fox3(+) CD25(+) CD4(+) T regulatory cells (Tregs) may transform the n-CoV's final destiny to CNS!
32880990 2020. Coronavirus Disease 2019 (COVID-19) is Associated with Low Circulating Plasma Levels of Angiotensin 1 and Angiotensin 1,7.
32726803 2020. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
32726801 2020. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
32726800 2020. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
32805734 2020. Structures and distributions of SARS-CoV-2 spike proteins on intact virions.
32807916 2020. COVID-19 poses a riddle for the immune system.
32826642 2020. A Novel Pediatric Multisystem Inflammatory Syndrome During the COVID-19 Pandemic.
32879033 2020. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
32843441 2020. COVID-19 Inflammatory Syndrome With Clinical Features Resembling Kawasaki Disease.
32812956 2020. Dynamical properties of enzyme-substrate complexes disclose substrate specificity of the SARS-CoV-2 main protease as characterized by the electron density descriptors.
32756685 2020. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.
32734714 2020. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
32875598 2020. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.
32826343 2020. Natural killer cell immunotypes related to COVID-19 disease severity.
31538715 2020. Updated phylogenetic analysis of the spike gene and identification of a novel recombinant porcine epidemic diarrhoea virus strain in Taiwan.
32492472 2020. How ISG15 combats viral infection.
32838495 2020. [Recognition of critical coronavirus disease 2019: from the injury of alveolar epithelial cells to vascular endothelial cells].


32738055 2020. Discrepancy between Sp O2 and Sa O2 in patients with COVID-19.
32776522 2020. An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
32885345 2020. The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach.
32835036 2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
32885781 2020. Pediatric Multisystemic Inflammatory Syndrome Associated With SARS-CoV-2 Infection.
32865490 2020. The Pathology of Severe COVID-19-Related Lung Damage.
32745993 2020. Vascular occlusion by neutrophil extracellular traps in COVID-19.
32736307 2020. The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19).
32857691 2020. Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020.
32730568 2020. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes.
32860146 2020. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy.
32883678 2020. Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome.
32747391 2020. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population.
32849623 2020. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
32793244 2020. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
32793223 2020. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.
32754163 2020. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.
32754162 2020. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.
32754159 2020. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
32733487 2020. Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.
32719688 2020. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
32719687 2020. Cell-Mediated Immune Responses to COVID-19 Infection.
32719686 2020. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
32849425 2020. Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.
32793182 2020. Geographic and Genomic Distribution of SARS-CoV-2 Mutations.
32719673 2020. In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles.
32793108 2020. The Consequences of Coronavirus-Induced Cytokine Storm Are Associated With Neurological Diseases, Which May Be Preventable.
32850560 2020. Quantitative Assessment of Parenchymal Involvement Using 3D Lung Model in Adolescent With Covid-19 Interstitial Pneumonia.
32719757 2020. SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association.
32754041 2020. Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.
32848893 2020. The Enigma of Endothelium in COVID-19.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32850603 2020. Improving Non-specific Immunity to Coronavirus Disease (COVID-19) by the Novelty, Diversity, and Quantity of Antigen.
32719819 2020. Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species.
32805314 2020. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).
32835214 2020. Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells.
32708319 2020. Computational Analysis of the Global Effects of Ly6E in the Immune Response to Coronavirus Infection Using Gene Networks.
32867305 2020. COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.
32858958 2020. Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
32822756 2020. Missense mutations in SARS-CoV2 genomes from Indian patients.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
32844125 2020. Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies.
32844126 2020. Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.
32835122 2020. Molecular biology of coronaviruses: current knowledge.
32835135 2020. Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications.
32750378 2020. A review of the main histopathological findings in coronavirus disease 2019.
32783921 2020. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.
32783920 2020. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival.
32791036 2020. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
32863636 2020. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
32746940 2020. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
32801801 2020. Effect of SARS-CoV-2 Infection on the Microbial Composition of Upper Airway.
32801787 2020. Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.
32765013 2020. Molecular Basis for Pathogenicity of Human Coronaviruses.
32771700 2020. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
32853823 2020. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2.
32737833 2020. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
32834892 2020. Macrophage activation syndrome and COVID-19.
32834891 2020. Genome evolution of SARS-CoV-2 and its virological characteristics.
32767095 2020. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality.
32844604 2020. Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2.
32790065 2020. A COVID-19 human viral challenge model. Learning from experience.
32838020 2020. SARS-CoV-2-human protein-protein interaction network.
32792851 2020. Immune Response and COVID-19: A mirror image of Sepsis.
32721529 2020. Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.
32771639 2020. Clinical immunity in discharged medical patients with COVID-19.
32771640 2020. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
32768699 2020. What can we learn from a COVID-19 lung biopsy?
32758688 2020. The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.
32866640 2020. Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends.
32861823 2020. Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
32841689 2020. A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic.
32841688 2020. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution.
32812365 2020. Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection.
32883007 2020. Natural Killer Cell Dysfunction and Its Role in COVID-19.
32630064 2020. Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections.
32867123 2020. Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops.
32767455 2020. Pediatric multisystem inflammatory syndrome temporally associated with SARS-COV-2: Oral manifestations and implications.
32779341 2020. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
32770345 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters.
32844260 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters. Author's reply.
32861856 2020. Age-Related Differences in Immunological Responses to SARS-CoV-2.
32742475 2020. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.
32835160 2020. The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection.
32867328 2020. Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors.
32873700 2020. Gene of the month: TMPRSS2 (transmembrane serine protease 2).
32722979 2020. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019.
32884216 2020. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.
32880929 2020. Molecular dynamics study with mutation shows that N-terminal domain (NTD) structural re-orientation in NPC1 is required for proper alignment of cholesterol transport.
32735721 2020. Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.
32762140 2020. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
32762081 2020. Is the COVID-19 thrombotic catastrophe complement-connected?
32860073 2020. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.
32770582 2020. Elucidating the microscopic and computational techniques to study the structure and pathology of SARS-CoVs.
32841626 2020. Sublingual microcirculation in patients with SARS-CoV-2 undergoing veno-venous extracorporeal membrane oxygenation.
32755094 2020. Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists.
32843733 2020. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19.
32817413 2020. Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency.
32794245 2020. A Japanese case of COVID-19: An autopsy report.
32863022 2020. Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect.
32809036 2020. Postmortale Bildgebung der Lunge bei COVID-19-Todesfallen.
32889497 2020. Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective.
32845122 2020. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.
32778542 2020. High oligoclonality of immunoglobulins in SARS-CoV2 positive patients.
30943371 2019. SARS coronavirus protein nsp1 disrupts localization of Nup93 from the nuclear pore complex.
32854812 2020. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
32776691 2020. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
32723800 2020. Fatal pulmonary fibrosis: a post-COVID-19 autopsy case.
32817204 2020. Histopathological observations in COVID-19: a systematic review.
32734876 2020. [Findings in post-mortem CT and autopsy in a 53-year-old-man with COVID-19].


32833435 2020. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
32806067 2020. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
32821883 2020. SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae but Not in Taste Buds or Embryonic Oral Epithelium.
32799392 2020. Kawasaki disease or Kawasaki-like disease: influence of SARS-CoV-2 infections in Japan.
32725143 2020. Phosphate metabolism and Respiratory Alkalosis: a forgotten lesson in COVID-19.
32754908 2020. Delayed virus-specific antibody responses associate with COVID-19 mortality.
32851645 2020. Angiotensin-converting enzyme II expression and its implication in the association between COVID-19 and allergic rhinitis.
32743884 2020. Blood Myeloperoxidase-DNA, a biomarker of early response to SARS-CoV-2 infection?
32808976 2020. Humoral Immune Response to SARS-CoV-2.
32755307 2020. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.
32878480 2020. Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium.
32755325 2020. The potential role of the carotid body in COVID-19.
31942559 2019. The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device.
32825305 2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Exhibits High Predicted Binding Affinity to ACE2 from Lagomorphs (Rabbits and Pikas).
32588590 2020. Coronaviruses fusion with the membrane and entry to the host cell.
32831935 2020. COVID-19: Lessons in laboratory medicine, pathology, and autopsy.
32821902 2020. The Spectrum of Histopathologic Findings in Lungs of Patients with Fatal COVID-19 Infection.
32829876 2020. Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.
31594639 2019. An in vivo cell-based assay for investigating the specific interaction between the SARS-CoV N-protein and its viral RNA packaging sequence.
32854762 2020. The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789.
32828489 2020. Epigenetic susceptibility to severe respiratory viral infections: pathogenic and therapeutic implications: a narrative review.
32805061 2020. COVID-19 and haemoglobin oxygen affinity: some clarity?
32743639 2020. Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV.
32742035 2020. Variant analysis of SARS-CoV-2 genomes.
32856707 2020. Viral dynamics and immune correlates of COVID-19 disease severity.
32844958 2020. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
32837710 2020. Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein.
32765822 2020. Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses.
32787909 2020. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients.
32778136 2020. A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection.
32880654 2020. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
32880957 2020. Variation and multilevel selection of SARS-CoV-2.
32890763 2020. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene.
32889094 2020. Inferring the genetic variability in Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques.
32890666 2020. Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 in the United States.
32725137 2020. Role of the early secretory pathway in SARS-CoV-2 infection.
32759312 2020. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.
32759311 2020. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2).
32848014 2020. Histopathological features of multiorgan percutaneous tissue core biopsy in patients with COVID-19.
32761894 2020. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
32678431 2020. Neutrophils and COVID-19: Nots, NETs, and knots.
32754556 2020. Is there antibody-dependent enhancement in SARS Coronavirus 2?
32787459 2020. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
32790406 2020. Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
32787330 2020. Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike.
32787225 2020. Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence.
32867854 2020. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
32746922 2020. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
31776274 2020. Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle.
31911390 2020. Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design.
32796155 2020. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
32838080 2020. SARS-CoV-2 Virions or Ubiquitous Cell Structures? Actual Dilemma in COVID-19 Era.
32822564 2020. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
32818434 2020. COVID-19 and multisystem inflammatory syndrome in children and adolescents.
32844161 2020. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.
32739876 2020. Autopsies of COVID-19 deceased? Absolutely!
32823907 2020. Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the Pandemic.
32735885 2020. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
32735883 2020. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
32768580 2020. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.
32871183 2020. Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
32835700 2020. Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies.
32822087 2020. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
32878932 2020. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
32878931 2020. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
32461278 2020. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells.
32874019 2020. Coronavirus herd immunity optimizer (CHIO).
32825438 2020. SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence.
32785274 2020. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
32780783 2020. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.
32780218 2020. A human circulating immune cell landscape in aging and COVID-19.
32822073 2020. Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein.
32777054 2020. Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster.
32876096 2021. CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE.
32876282 2020. MULTISYSTEM INFLAMMATORY SYNDROME IN A CHILD ASSOCIATED WITH CORONAVIRUS DISEASE 19 IN THE BRAZILIAN AMAZON: FATAL OUTCOME IN AN INFANT.
32611651 2020. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic.
32699064 2020. Viral subversion of nonsense-mediated mRNA decay.
32747912 2020. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection.
32838198 2020. Lung Barrier Function in COVID-19?
32642005 2020. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
32839288 2020. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients.
32851697 2020. Single-cell RNA expression profiling of ACE2 and TMPRSS2 in the human trophectoderm and placenta.
32798244 2020. Anatomical and timely assessment of protein expression of angiotensin-converting enzyme 2, SARS-CoV-2 specific receptor, in fetal and placental tissues: new insight for perinatal counseling.
32551795 2020. Coronaviruses.
32732586 2020. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID 19): What we know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects.
32366572 2020. The Biology of Pulmonary Coronavirus Infection Underscores Host-Directed Therapies as an Option.
32826274 2020. Response to: 'Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries?' by Yamashita et al.
32529459 2020. Genome-wide analysis of long noncoding RNA profiles in Vero cells infected with porcine epidemic diarrhea virus.
32730589 2020. Persistent minimal sequences of SARS-CoV-2.
32818261 2020. Structural basis of SARS-CoV-2 spike protein induced by ACE2.
32805023 2020. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
32877502 2020. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.
32737031 2020. Cellular immune responses to covid-19.
32871617 2020. The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective.
32628899 2020. Coronaviruses and Integrin alphavbeta3: Does Thyroid Hormone Modify the Relationship?
32749914 2020. Resolution of coronavirus disease 2019 (COVID-19).
32878546 2020. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
32845733 2020. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
32841579 2020. Cytokines and COVID-19: friends or foes?
32753027 2020. Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein.
32738851 2020. Can a Healthy Lung Keep the COVID-19 Away?
32889794 2020. SARS-CoV-2 infection, oxidative stress and male reproductive hormones: can testicular-adrenal crosstalk be ruled-out?
32013309 2020. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.
32744052 2020. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
32828084 2020. Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states.
32886755 2020. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
32841329 2020. Underlying Vulnerabilities to the Cytokine Storm and Adverse COVID-19 Outcomes in the Aging Immune System.
32731783 2020. Novel coronavirus infection and Kawasaki disease.
32846427 2020. Sex differences in immune responses that underlie COVID-19 disease outcomes.
32776761 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): providing resuscitative care.
32882717 2020. Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis.
32882716 2020. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).


32766671 2020. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19.
32735892 2020. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
32838215 2020. An Impaired Natriuretic Peptide Hormone System May Play a Role in COVID-19 Severity in Vulnerable Populations.
32779891 2020. Sympathetic activation: a potential link between comorbidities and COVID-19.
32790936 2020. Nicotine and the nicotinic cholinergic system in COVID-19.
32738184 2020. Tumor markers as an entry for SARS-CoV-2 infection?
32760733 2020. Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report.
32866507 2020. Fever and diarrhea as the only symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C).
32769230 2020. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
32441271 2020. Novel Coronavirus Mimicking Kawasaki Disease in an Infant.
32788432 2020. Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India.
32738607 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
32812719 2020. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
32763970 2020. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection.
32713862 2020. RNAi suppressor: The hidden weapon of SARS-CoV.
32840072 2020. [The mechanism and treatment strategies of SARS-CoV-2 mediated inflammatory response].
32859733 2020. Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19.
32852402 2020. Histopatological Findings in the Explant Lungs of a Patient With COVID-19 Treated With Bilateral Orthotopic Lung Transplant.
32762171 2020. [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV].
32762165 2020. [Replication and transmission mechanisms of highly pathogenic human coronavirus].


32725143 2020. Phosphate metabolism and Respiratory Alkalosis: a forgotten lesson in COVID-19.
32726150 2020. Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19.
32735900 2020. Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses.
32737584 2020. A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
32728349 2020. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients.
32745829 2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.
32721790 2020. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics.
32743639 2020. Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV.
32707576 2020. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
32728199 2020. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.
32725381 2020. Interaction of HSPA5 (Grp78, BIP) with negatively charged phospholipid membranes via oligomerization involving the N-terminal end domain.
32722449 2020. A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2.
32770235 2020. Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients.
32745196 2020. Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection.
32742654 2020. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.
32771962 2020. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
32742881 2020. Pediatric Case of Severe COVID-19 With Shock and Multisystem Inflammation.
32775080 2020. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
32767259 2020. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients.
32745993 2020. Vascular occlusion by neutrophil extracellular traps in COVID-19.
32749957 2020. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.
32752979 2020. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
32691695 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
32730568 2020. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes.
32735892 2020. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
32738184 2020. Tumor markers as an entry for SARS-CoV-2 infection?
32741461 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?
32765596 2020. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein.
32765592 2020. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
32754162 2020. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.
32754159 2020. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
32733448 2020. Role of Autophagy in Lung Inflammation.
32719688 2020. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
32719687 2020. Cell-Mediated Immune Responses to COVID-19 Infection.
32719686 2020. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
32737833 2020. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
32720978 2020. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
32721529 2020. Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.
32738607 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
32730233 2020. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
32730226 2020. Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?
32739486 2020. Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
32726448 2020. IFITM3 related to COVID-19.
32726417 2020. Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections.
32738141 2020. Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients.
32735721 2020. Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.
32735785 2020. Lung fibrosis: an undervalued finding in COVID-19 pathological series.
32739471 2020. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
32735885 2020. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
32735883 2020. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
32732237 2020. Genome Sequences of SARS-CoV-2 Strains Detected in Hong Kong.
32732236 2020. Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh.
32732235 2020. SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology.
32744436 2020. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
32733001 2020. Activation and evasion of type I interferon responses by SARS-CoV-2.
32737462 2020. IgGs drive COVID-19 myeloid hyperinflammation.
32732951 2020. NK cells in COVID-19: protectors or opponents?
32728222 2020. T cell responses in patients with COVID-19.
32728221 2020. Tissue damage from neutrophil-induced oxidative stress in COVID-19.
32724189 2020. Rising to the challenge of COVID-19.
32722596 2020. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
32721181 2020. Immunometabolic Status of COVID-19 Cancer Patients.
32780783 2020. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.
32726325 2020. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.
32726355 2020. Interplay between SARS-CoV-2 and the type I interferon response.
32738789 2020. Nox2 activation in Covid-19.
32727465 2020. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
32723327 2020. The pathophysiology of 'happy' hypoxemia in COVID-19.
32703906 2020. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
32661059 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
32728018 2020. Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.
32712629 2020. COVID-19: immunopathogenesis and Immunotherapeutics.
32720214 2020. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
32705575 2020. Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity.
32717345 2020. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
32730781 2020. Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
32730780 2020. 100 days of solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE program.
32732586 2020. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID 19): What we know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects.
32734595 2020. Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.
32726474 2020. SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age.
32675499 2020. Tracheobronchial Slough, a Potential Pathology in Endotracheal Tube Obstruction in Patients With Coronavirus Disease 2019 (COVID-19) in the Intensive Care Setting.
32730589 2020. Persistent minimal sequences of SARS-CoV-2.
32737031 2020. Cellular immune responses to covid-19.
32735457 2020. The vascular nature of COVID-19.
32697499 2020. Dealing With the CARDS of COVID-19.
32749095 2020. MAIT Cells in COVID-19: Heroes, Villains, or Both?
32749094 2020. Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.
32628899 2020. Coronaviruses and Integrin alphavbeta3: Does Thyroid Hormone Modify the Relationship?
32654788 2020. Histological characterization of placenta in COVID19 pregnant women.
32773420 2020. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.
32727719 2020. Postmortem Kidney Pathology Findings in Patients with COVID-19.
32723800 2020. Fatal pulmonary fibrosis: a post-COVID-19 autopsy case.
32744884 2020. COVID-19, Mitochondria, and Interferon.
32721252 2020. Eosinophil-Derived Neurotoxin and Respiratory Tract Infection and Inflammation: Implications for COVID 19 Management.
32731783 2020. Novel coronavirus infection and Kawasaki disease.
32770807 2020. Kawasaki disease fact check: Myths, misconceptions and mysteries.
32740530 2020. COVID-19-Associated Multisystem Inflammatory Syndrome in Children Presenting as Acute Pancreatitis.
32739908 2020. COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice.
32726507 2020. Hypoxia - an overlooked trigger for thrombosis in COVID-19 and other critically ill patients.
32730555 2020. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.
32725017 2020. Quantitative determination of mechanical stability in the novel coronavirus spike protein.
32724171 2020. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic.
32737467 2020. A thermostable, closed SARS-CoV-2 spike protein trimer.
32726803 2020. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
32726801 2020. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
32677813 2020. Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19.
32639461 2020. Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection.
32734714 2020. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
32753554 2020. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.


32747721 2020. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
32773102 2020. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
32773100 2020. NK cells: A double edge sword against SARS-CoV-2.
32706115 2020. Relative lymphocytosis in COVID-19 - a ray of hope.
32754908 2020. Delayed virus-specific antibody responses associate with COVID-19 mortality.
32755307 2020. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.
32755325 2020. The potential role of the Carotid Body in COVID-19.
32761524 2020. Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?
32759839 2020. Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?
32749662 2020. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
32762083 2020. Neuropathologic features of four autopsied COVID-19 patients.
32778874 2020. Pathogenetic profiling of COVID-19 and SARS-like viruses.
32742035 2020. Variant analysis of SARS-CoV-2 genomes.
32733733 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection.
32730807 2020. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.
32759967 2020. Dysregulated adaptive immune response contributes to severe COVID-19.
32753756 2020. SARS-CoV-2 infects human neural progenitor cells and brain organoids.
32754823 2020. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19.
32611087 2020. Topological analysis of SARS CoV-2 main protease.
32690231 2020. The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy.
32753517 2020. Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF.
32758273 2020. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
32749472 2020. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
32765822 2020. Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
32752129 2020. Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.
32766671 2020. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19.
32779891 2020. Sympathetic activation: a potential link between comorbidities and COVID-19.
32760733 2020. Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report.
32719673 2020. In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles.
32719672 2020. Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy.
32719757 2020. SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association.
32765270 2020. The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection.
32754041 2020. Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32754569 2020. Clinical Characteristics and Eosinophils in Young SARS-CoV-2-Positive Chinese Travelers Returning to Shanghai.
32769230 2020. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
32746940 2020. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
32765013 2020. Molecular Basis for Pathogenicity of Human Coronaviruses.
32771700 2020. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
32767095 2020. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality.
32760213 2020. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients.
32771640 2020. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
32768699 2020. What can we learn from a COVID-19 lung biopsy?
32763446 2020. Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19.
32767018 2020. Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.
32767455 2020. Pediatric multisystem inflammatory syndrome temporally associated with SARS-COV-2: Oral manifestations and implications.
32779341 2020. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
32770345 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters.
32756323 2020. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic.
32759312 2020. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.
32763812 2020. The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong.
32777762 2020. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.
32779780 2020. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.
32678431 2020. Neutrophils and COVID-19: Nots, NETs, and knots.
32779742 2020. A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease?
32761905 2020. Comment on Hu et al: The cytokine storm and COVID-19.
32779784 2020. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
32776556 2020. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 Patients.
32762140 2020. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
32756980 2020. Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report.
32733785 2020. Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2.
32768580 2020. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.
32724296 2020. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.
32755094 2020. Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists.
32778817 2020. A paradox of social distancing for SARS-CoV-2: loneliness and heightened immunological risk.
32764693 2020. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells.
32764665 2020. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.
32780218 2020. A human circulating immune cell landscape in aging and COVID-19.
32743565 2020. Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators.
32611651 2020. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
32669297 2020. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
32661058 2020. Structural basis of a shared antibody response to SARS-CoV-2.
32771430 2020. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
32722574 2020. In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.
32732269 2020. COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?
32755212 2020. Imaging Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19
32755507 2020. Rewiring the Immune Response in COVID-19.
32778542 2020. High oligoclonality of immunoglobulins in SARS-CoV2 positive patients.
32720486 2020. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.
32779445 2020. Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients.
32772742 2020. Non-chemical signatures of biological materials: Radio signals from Covid19?
32750889 2020. AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells.
32773417 2020. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis.
32753027 2020. Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein.
32776691 2020. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
32744052 2020. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
32773643 2020. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32723457 2020. Silent Hypoxia in COVID-19: What is Old is New Again!
32723446 2020. A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19).
32769685 2020. Immunity, inflammation and the vasculature in the COVID-19 era.
32729633 2020. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
32780968 2020. Four months into the COVID-19 pandemic, Sweden's prized herd immunity is nowhere in sight.
32631657 2020. Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases.
32778886 2020. Multi-System Inflammatory Syndrome in a Child Mimicking Kawasaki Disease.
32780125 2020. Regulatory T Cells Tested in Patients With COVID-19 ARDS.
32758881 2020. SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol).
32762609 2020. A Novel Hypothesis for Original Antigenic Sin in the Severe Disease of SARS-CoV-2 Infection.
32747830 2020. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.
32753755 2020. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation.
32776761 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): providing resuscitative care.
32756685 2020. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.
32748124 2020. Endo-Lysosomal Cation Channels and Infectious Diseases.
32732280 2020. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
32631885 2020. Rewilding immunology.
32694201 2020. Distinct conformational states of SARS-CoV-2 spike protein.
32675364 2020. Aging immunity may exacerbate COVID-19.
32675355 2020. The pandemic virus is slowly mutating. But does it matter?
32762171 2020. [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV].
32762165 2020. [Replication and transmission mechanisms of highly pathogenic human coronavirus].


32765942 2020. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.
32765940 2020. Decreased Naive T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.
32656827 2020. Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19.
32750108 2020. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
32750378 2020. A review of the main histopathological findings in the Coronavirus Disease 2019 (COVID-19).
32681497 2020. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
32713862 2020. RNAi suppressor: The hidden weapon of SARS-CoV.
32742475 2020. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.
32761894 2020. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
32773261 2020. SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem.
32727811 2020. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
32736274 2020. Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function?
32768467 2020. Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function Following Multisystem Inflammatory Syndrome in Children (MIS-C).
32768466 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review.
32746922 2020. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
32759577 2020. Role of cytotoxic T lymphocytes and interferon-gamma in coronavirus infection: lessons from murine coronavirus infections in mice.
32778426 2020. Reacciones cruzadas entre factor reumatoide e IgM SARS-CoV-2.
32759016 2020. Estrogen shields women from COVID-19 complications by reducing ER stress.
32758906 2020. Are night shift workers at an increased risk for COVID-19?
32759006 2020. Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity.
32759008 2020. Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.
32759007 2020. Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.
32758903 2020. Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.
32758901 2020. Acute respiratory distress syndrome from Covid-19: A perfect storm from free radicals? Proposal for a new treatment.
32721809 2020. Kawasaki-like disease in children with COVID-19: A hypothesis.
32721808 2020. Prior infection with intestinal coronaviruses moderates symptom severity and mortality in patients with COVID-19: A hypothesis and preliminary evidence.
32769902 2020. Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report.
32741970 2020. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.
32723797 2020. Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution.
32750256 2020. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester.
32742818 2020. RdRp mutations are associated with SARS-CoV-2 genome evolution.
32742815 2020. Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.
32684101 2020. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
32769398 2020. Shedding Light on COVID-19: ADAM17 the Missing Link?
32759264 2020. Correspondence on: 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al.
32759261 2020. Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al.
32633334 2020. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43.
32746720 2020. Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods.
32725137 2020. Role of the early secretory pathway in SARS-CoV-2 infection.

012


head
32669777 2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge von Willebrand Factor (eULVWF) Decorated-Platelet Strings.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
32671009 2020. Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37.
C7255426 ?. Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2.
32658591 ?. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
C7236793 ?. Prediction and analysis of key protein structures of 2019-nCoV.
C7341045 2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
C7323676 ?. Coronavirus disease 2019 (COVID-19): cytokine storms hyper-inflammatory phenotypes and acute respiratory distress syndrome.
C7264919 ?. Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains.
32668194 ?. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
32659347 2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.
C7308782 2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.
32683296 2020. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
32669955 2020. A comprehensive investigation of the mRNA and protein level of ACE2 the putative receptor of SARS-CoV-2 in human tissues and blood cells.
C7274027 ?. The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development.
32659712 2020. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.
32707511 2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
32674001 2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis a case series.
32661206 2020. Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human.
C7358169 ?. Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
C7332243 ?. Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection.
C7323226 ?. Cancer Prevales on Covid?19: To Maintain a High Quality Standard Concerning Diagnosis and Oncological Care Even During a Pandemic.
C7351386 ?. Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions.
C7311326 2020. Coronavirus disease 2019?related Kawasaki-like disease in an adult: A case report.
C7314447 ?. Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.
C7296312 ?. Children at risk: multisystem inflammatory syndrome and COVID-19.
C7316659 ?. Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.
C7275990 ?. COVID-19?Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.
32659211 2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
C7292579 2020. Genotyping SARS-CoV-2 through an interactive web application.
C7266609 2020. An integrated national scale SARS-CoV-2 genomic surveillance network.
C7351415 ?. Severe refractory Kawasaki disease in seven infants in the COVID-19 era.
C7259908 2020. Coronavirus is the trigger but the immune response is deadly.
C7234786 2020. Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases.
32680625 2020. Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
C7256601 ?. In Reply?The ?Perfect Cytokine Storm? of COVID-19.
C7256539 2020. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19).
C7256537 ?. THE ?PERFECT CYTOKINE STORM? OF COVID-19.
32721799 2020. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression.
32679425 2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
32679426 2020. The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19?.
32673940 2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
32679424 2020. Natural protection of ocular surface from viral infections ? A hypothesis.
32688183 2020. Corrigendum to ?COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming?? [Med Hypothesis 144 (2020) 109918].
C7326438 2020. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.
C7322475 2020. COVID-19: NAD+ deficiency may predispose the aged obese and type2 diabetics to mortality through its effect on SIRT1 activity.
C7313490 2020. Understanding Covid and the associated post-infectious hyper-inflammatory state (PIMS-TS) in children.
C7313483 2020. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.
32670517 2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.
32670592 2020. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.
C7334952 2020. Pathologic features of COVID-19: A concise review.
32703502 2020. Autopsy of patients with COVID-19: A balance of fear and curiosity.
C7346848 2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
C7328593 2020. Behavioral immune system linked to responses to the threat of COVID-19.
C7329651 ?. Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case report.
C7244417 ?. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach.
32713710 ?. Neuropsychiatric Symptoms in an Adolescent Boy With Multisystem Inflammatory Syndrome in Children.
C7335763 ?. Histopathologische Befunde bei therapierter und nichttherapierter SARS-CoV-2-Infektion ? Bericht über 3 Autopsien.
C7335629 ?. Der erste COVID-19-Hotspot in einer Hamburger Senioreneinrichtung: Präventionskonzept Letalität und Obduktionsbefunde.
C7247437 ?. Evidence for systematic autopsies in COVID-19 positive deceased: Case report of the first German investigated COVID-19 death.
C7311357 2020. Expression profiling meta-analysis of ACE2 and TMPRSS2 the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells and identification of putative modulators.
32702724 ?. Age-dependent assessment of genes involved in cellular senescence telomere and mitochondrial pathways in human lung tissue of smokers COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis .
32702726 ?. SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyper-activation .
32702716 ?. Can Hyperperfusion of Nonaerated Lung Explain COVID-19 Hypoxia? .
32702718 ?. E-cigarette-Induced Pulmonary Inflammation and Dysregulated Repair are Mediated by nAChR ?7 Receptor: Role of nAChR ?7 in ACE2 Covid-19 receptor regulation.
32702714 ?. Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.
32702737 ?. B cell clonal expansion and convergent antibody responses to SARS-CoV-2.
32702728 ?. A potential role for AHR in SARS-CoV-2 pathology.
C7347481 2020. Hemophagocytic syndrome and COVID-19.
C7328624 2020. Sars-CoV-2 et Kawasaki rapprochement ? risque.
C7297549 ?. Kawasaki Disease and Invasive Pneumococcal Infection.
32680648 ?. Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak. head
C7340772 ?. Prototype of a Smart Microfluidic Platform for the Evaluation of SARS-Cov-2 Pathogenesis Along with Estimation of the Effectiveness of Potential Drug Candidates and Antigen?Antibody Interactions in Convalescent Plasma Therapy.
C7358563 2020. Unleashing the mysterious link between COVID-19 and a famous childhood vasculitis: Kawasaki disease.
C7320653 ?. Fractal signature of coronaviruses related to severe acute respiratory syndrome.
C7318729 2020. Gemeinschaftlich in Krisenzeiten: NMR-Strukturbiologie gegen COVID-19.
C7297671 2020. Covid-19: An urgent need for a psychoneuroendocrine perspective.
C7344205 2020. Crystal Structure of the Main Protease of Human Coronavirus NL63.
C7225694 2020. COVID-19 y estudios microbiológicos post mortem.
C7211634 2020. Autopsias en casos sospechosos de SARS-CoV-2.
C7211618 2020. Gestión de los cadáveres durante la pandemia por COVID-19 en España.
C7334659 2020. Devilishly radical NETwork in COVID-19: Oxidative stress neutrophil extracellular traps (NETs) and T cell suppression.
C7292949 2020. NK cells: A double edge sword against SARS-CoV-2.
C7315969 ?. COVID-19 and preeclampsia with severe features at 34-weeks gestation.
32668317 ?. COVID-19?Related Collapsing Glomerulopathy in a Kidney Transplant Recipient.
32659225 ?. The role of a cytokine storm in severe COVID-19 disease in pregnancy.
32659620 2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.
C7314264 ?. Human neutralizing antibodies to SARS-CoV-2: views and perspectives from Professor Linqi Zhang at Tsinghua University.
32718664 ?. Afectación endotelial por COVID-19 en criobiopsia pulmonar.
32682575 ?. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
C7323440 ?. Children s (and autoimmune patients) morbidity (and mortality) from Covid?19 is similar to the general population: immunologic rationale.
C7305885 2020. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
32703419 2020. Proteasome activator PA28?-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
C7356136 2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
32601146 2020. Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.
32665075 ?. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.
C7308744 2020. Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk.
32673567 ?. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32697970 ?. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
32697968 ?. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
C7091918 ?. COVID-19 infection: the perspectives on immune responses.
32735849 ?. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.
32668215 2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
C7276302 2020. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32673668 2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
32673711 2020. mTORC inhibitor Sirolimus deprograms monocytes in ?cytokine storm? in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome.
32659373 2020. Long-term infection of SARS-CoV-2 changed the body s immune status.
C7245680 ?. Hyperinflammation with COVID-19: The key to patient deterioration????.
C7354860 2020. Citrullinated histone H3 a marker of extracellular trap formation is increased in blood of stable asthma patients.
32696004 2020. Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors.
32711241 2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
C7287426 ?. On the evolutionary epidemiology of SARS-CoV-2.
C7328575 ?. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.
C7354376 ?. Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays.
32711184 2020. The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2.
C7335417 ?. Assessment of samples pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia.
32673978 2020. How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory.
32731192 2020. COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic.
C7316051 2020. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.
C7305505 2020. Tocilizumab for treatment of patients with severe COVID?19: A retrospective cohort study.
C7245291 ?. EL CUIDADO HUMANIZADO EN LA MUERTE POR COVID-19: A PROPÓSITO DE UN CASO.
C7357538 ?. Particulate matter (PM10) enhances RNA virus infection through modulation of innate immune responses?.
C7358302 ?. A Study on Herd Immunity of COVID-19 in South Korea: Using a Stochastic Economic-Epidemiological Model.
32665942 2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
C7267447 2020. An address to the European immunology community concerning the Coronavirus pandemic.
C7318732 2020. Can India develop herd immunity against COVID-19?
C7262083 ?. SARS?CoV?2 an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability.
C7337683 ?. Lions Tigers and Kittens too: ACE2 and susceptibility to CoVID-19.
C7337764 ?. COVID-19 and Evolutionary Medicine.
C7324322 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?


32656452 2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
32631771 2020. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.
32598981 2020. Infections and Collapsing Glomerulopathy.
32564928 2020. Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges.
32653819 2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.
32571869 2020. Kawasaki disease or Kawasaki syndrome?
32489438 2020. Spectrum of histopathological findings in coronavirus disease-19, Middle East respiratory syndrome and severe acute respiratory syndrome.
32565134 2020. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
32533513 2020. Cytosolic DNA sensing through cGAS and STING is inactivated by gene mutations in pangolins.
32405132 2020. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury.
32653765 2020. Immunosenescence exacerbates the COVID-19.
32611485 2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32559654 2020. Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling.
32646445 2020. Isolation and characterization of WUPyV in polarized human airway epithelial cells.
32618551 2020. Covid-19 and Kawasaki syndrome.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32645326 2020. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
32649876 2020. Human Virus Transcriptional Regulators.
32623480 2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
32623546 2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
32632255 2020. Pulmonary alveolar regeneration in adult COVID-19 patients.
32612199 2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
32622823 2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
32622819 2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
32118646 2020. Voice from China: nomenclature of the novel coronavirus and related diseases.
32118645 2020. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-novel coronavirus.
32653658 2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.
32533338 2020. A 9-year-old girl with Kawasaki disease and pulmonary nodules.
32418043 2020. Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis.
32513224 2020. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.
32541570 2020. Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 ARDS Patients With Near-Normal Respiratory Compliance.
32642354 2020. Do COVID-19 and SARS Gene Complexities and Variations Help Overcome the Knowledge Gap?
32428465 2020. Pandemics and the great evolutionary mismatch.
32563779 2020. Protective and pathogenic roles for mast cells during viral infections.
32484440 2020. Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells.
32617121 2020. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019.
24935083 2015. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.
23452147 2013. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.
32641214 2020. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.
32637365 2020. Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier.
32655580 2020. Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?
32655579 2020. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.
32612617 2020. The COVID-19 Cytokine Storm; What We Know So Far.
32582219 2020. IL-22 Plays a Critical Role in Maintaining Epithelial Integrity During Pulmonary Infection.
32574256 2020. Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection.
32626680 2020. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study.
32392463 2020. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.
32294404 2020. Something Else to Stress about: Perinatal Stress Attenuates CD8(+) T Cell Activity in Adults.
32500198 2020. Corona deaths in Hamburg, Germany.
32626922 2020. A dissection of SARSCoV2 with clinical implications (Review).
32466119 2020. Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.
32365944 2020. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
32340172 2020. Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway.
32488343 2020. Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients.
32385629 2020. From the quarantine diary of an emergency physician: the coronavirus and the dysautonomic storm.
17340620 2007. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung.
28063205 2017. Pathogenetic determinants in Kawasaki disease: the haematological point of view.
30146782 2019. Modulation of the immune response by Middle East respiratory syndrome coronavirus.
32648027 2020. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
32623351 2020. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates.
16752365 2006. Coronavirus phylogeny based on 2D graphical representation of DNA sequence.
32006540 2020. Genetic diversity and potential recombination between ferret coronaviruses from European and American lineages.
32142930 2020. Insights into the cross-species evolution of 2019 novel coronavirus.
26287378 2016. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.
24760654 2014. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.
32585239 2020. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.
32441751 2020. Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome.
32582339 2020. Variation of 2019 novel coronavirus complete genomes recorded in the 1(st) month of outbreak: Implication for mutation.
32188728 2020. Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
26269185 2015. Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.
24478444 2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
16940539 2006. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein.
32432657 2020. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.
32437764 2020. Visualization of putative coronavirus in kidney.
32505464 2020. Am I a coronavirus?
32653518 2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
32498008 2020. Is the gingival sulcus a potential niche for SARS-Corona virus-2?
32652428 2020. Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?
32634734 2020. Hypoxemia in COVID-19 patients: An hypothesis.
32653475 2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?
32656314 2020. COVID-19-A theory of autoimmunity to ACE-2.
25077179 2014. Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.
32598829 2020. Childhood Multisystem Inflammatory Syndrome - A New Challenge in the Pandemic.
32461612 2020. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.
32555182 2020. Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution.
32651568 2020. T cell renaissance in COVID-19.
32591759 2020. Caught by NETs.
32591758 2020. Transient IgA, steady IgG?
32533112 2020. Neutralizing antibodies in convalescent patients.
32533130 2020. Epigenetic and epitranscriptomic regulation of viral replication.
32561857 2020. Coronavirus replication factories.
32287794 2020. Wuhan-like virus discovered seven years ago.
31863580 2020. A nucleobase-binding pocket in a viral RNA-dependent RNA polymerase contributes to elongation complex stability.
30070073 2018. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease.
28950425 2018. Pulmonary presentation of Kawasaki disease-A diagnostic challenge.
22022266 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
32620366 2020. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
32611518 2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
32650970 2020. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.
32650969 2020. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic.
32434680 2020. AID in Antibody Diversification: There and Back Again.
32651761 2020. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.
28738245 2017. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication.
18045721 2008. SARS coronavirus accessory proteins.
32456011 2020. The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses.
32331321 2020. Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?


32656452 2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
32712145 2020. Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult.
32659225 2020. The role of a cytokine storm in severe COVID-19 disease in pregnancy.
32701539 2020. HLA-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.
32659620 2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.
32653819 2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.
32676824 2020. Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.
32708525 2020. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.
32669265 2020. Discovery of M Protease inhibitors encoded by SARS-CoV-2.
32708430 2020. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.
32653765 2020. Immunosenescence exacerbates the COVID-19.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32717432 2020. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
32685484 2020. Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.
32664932 2020. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
32664879 2020. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
32665075 2020. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.
32708264 2020. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32697970 2020. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
32697968 2020. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
32673567 2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32690996 2020. COVID-19 infection: mitohormetic concept of immune response.
32697943 2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.
32612152 2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.
32623480 2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
32712910 2020. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
32623546 2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
32668215 2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
32632255 2020. Pulmonary alveolar regeneration in adult COVID-19 patients.
32612199 2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32619549 2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
32660065 2020. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
32635598 2020. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.
32707842 2020. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.
32622823 2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
32707182 2020. Novel Temperature Trajectory Subphenotypes in COVID-19.
32622819 2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
32630212 2020. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
32700055 2020. The extended autonomic system, dyshomeostasis, and COVID-19.
32671502 2020. Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis.
32661775 2020. Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna's Autonomic Unit.
32673668 2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
32683814 2020. Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic?
32664709 2020. Immunopathogenesis of COVID-19 and early immunomodulators.
32712394 2020. Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation?
32659373 2020. Long-term infection of SARS-CoV-2 changed the body's immune status.
32653662 2020. Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
32653658 2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.
32717416 2020. Evolution of viral quasispecies during SARS-CoV-2 infection.
32711057 2020. Viable SARS-CoV-2 in various specimens from COVID-19 patients.
32688067 2020. Body temperature and host species preferences of SARS-CoV-2.
32658736 2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.
32709253 2020. Response to "Body temperature correlates with mortality in COVID-19 patients".
32698857 2020. Could the severity of COVID-19 be increased by low gastric acidity?
32690058 2020. Detection of IgG antibody during the follow-up in patients with COVID-19 infection.
32711241 2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
32685628 2020. Haematological and immunological data of Chinese children infected with coronavirus disease 2019.
32707212 2020. Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus.
32665025 2020. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2.
32699547 2020. Kawasaki disease in siblings and a review of drug treatment.
32711256 2020. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.
32711254 2020. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.
32707445 2020. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.
32717182 2020. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
32712315 2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
32707288 2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
32668462 2020. COVID-19: An Immunopathologic Assault.
32709193 2020. Lung Injury in COVID-19-An Emerging Hypothesis.
32673476 2020. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.
32672403 2020. microRNAs as new possible actors in gender disparities of Covid-19 pandemic.
32662161 2020. Covid-19, ACE2, and the kidney.
32681166 2020. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
32666092 2020. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
32662111 2020. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes.
32706609 2020. Inducible Epithelial Resistance Against Coronavirus Pneumonia in Mice.
32663409 2020. Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2.
32662396 2020. Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients.
32705809 2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1.
32716641 2020. Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model.
32686774 2020. Multiple sclerosis and COVID-19.
32654296 2020. A Tale of (Glycogen Synthase Kinase) Three: Lithium, The Kidney and Coronavirus Disease 19.
32679621 2020. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
32678953 2020. Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series.
32678950 2020. Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.
32663362 2020. ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.
32654514 2020. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression.
32689809 2020. Unexpected Features of Cardiac Pathology in COVID-19 Infection.
32706417 2020. Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19.
32717055 2020. Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.
32710613 2020. Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.
32672790 2020. Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.
32667973 2020. SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.
32663256 2020. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.
32694169 2020. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
32713339 2020. Viral Evolution will Automatically Resolve COVID-19 Pandemic.
32660402 2020. NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2.
32657802 2020. Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: menage a trois.
32675718 2020. Reflections on rheumatological aspects of COVID-19.
32654350 2020. Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection.
32662099 2020. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.
32657473 2020. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.
32652001 2020. Endocrine significance of SARS-CoV-2's reliance on ACE2.
32686577 2020. Epigenetic mechanisms regulating COVID-19 infection.
32710612 2020. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.
32643968 2020. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.
32706090 2020. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.
32692465 2020. COVID-19, Cilia, and Smell.
32692408 2020. Third Trimester Placentas of SARS-CoV-2-Positive Women: Histomorphology, including Viral Immunohistochemistry and in Situ Hybridization.
32678695 2020. Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.
32689852 2020. Immune Responses to the Novel Coronavirus-2: Friend or Foe?


32662421 2020. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
32665942 2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
32675207 2020. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.
32675206 2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.
32703822 2020. Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge.
32714336 2020. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.
32676080 2020. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
32695025 2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.
32676039 2020. COVID-19 Sepsis and Microcirculation Dysfunction.
32658591 2020. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
32682765 2020. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19.
32668194 2020. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
32659267 2020. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.
32683337 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.
32683336 2020. Hyperinflammatory Syndrome in Children Associated with COVID-19: Need for Awareness.
32659347 2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.
32708334 2020. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
32668803 2020. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
32664543 2020. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.
32681297 2020. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
32666177 2020. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.
32695405 2020. COVID-19 and cryo-EM.
32675285 2020. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.
32701511 2020. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children.
32708872 2020. Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.
32674356 2020. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.
32690544 2020. Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2.
32707511 2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
32674001 2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
32652214 2020. Factors affecting stability and infectivity of SARS-CoV-2.
32699345 2020. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.
32675312 2020. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.
32652168 2020. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).
32718895 2020. Immune response in COVID-19: A review.
32707537 2020. Hazards of the cytokine storm and cytokine-targeted therapy in COVID-19 patients: A Review.
32627759 2020. An Overview of the Genetic Variations of the SARS-CoV-2 Genomes Isolated in Southeast Asian Countries.
32710986 2020. Mutations Strengthened SARS-CoV-2 Infectivity.
32717229 2020. Epidemiological trends in Kawasaki disease during COVID-19 in Singapore.
32661139 2020. Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
32706339 2020. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
32687484 2020. Severe immunosuppression and not a cytokine storm characterize COVID-19 infections.
32659211 2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
32682491 2020. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
32653054 2020. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
32653518 2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
32693241 2020. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
32687918 2020. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
32703818 2020. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
32694143 2020. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.
32679426 2020. The <> able to explain the Th1 immune lockdown in severe COVID-19.
32679424 2020. Natural protection of ocular surface from viral infections - A hypothesis.
32673940 2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
32683222 2020. The immunomodulatory effects of exercise against COVID-19.
32679425 2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
32664116 2020. Late histological findings in symptomatic COVID-19 patients: A case report.
32670525 2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.
32670517 2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.
32653475 2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?
32710269 2020. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.
32709887 2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.
32709886 2020. Structural basis of RNA cap modification by SARS-CoV-2.
32708840 2020. Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection.
32672799 2020. Eosinopenia and COVID-19.
32680910 2020. Kidney Biopsy Findings in Patients with COVID-19.
32675304 2020. Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19.
32669323 2020. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.
32660970 2020. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.
32651224 2020. Caution in Identifying Coronaviruses by Electron Microscopy.
32700513 2020. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?
32660959 2020. Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva?
32667280 2020. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
32699160 2020. COVID-19: Complement, Coagulation, and Collateral Damage.
32696489 2020. Cytokine storm syndrome in coronavirus disease 2019: A narrative review.
32716059 2020. Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".
32710647 2020. Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.
32706425 2020. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.
32706420 2020. Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.
32706410 2020. SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.
32706407 2020. SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.
32681651 2020. COVID-19: What type of cytokine storm are we dealing with?
32699095 2020. Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
32679087 2020. COVID-19: from rapid genome sequencing to fast decisions.
32654359 2020. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.
32687176 2020. Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design.
32706959 2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
32706954 2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
32678534 2020. Pulmonary Vascular Pathology in Covid-19. Reply.
32678533 2020. Pulmonary Vascular Pathology in Covid-19.
32678532 2020. Pulmonary Vascular Pathology in Covid-19.
32678531 2020. Pulmonary Vascular Pathology in Covid-19.
32719485 2020. Sampling the host response to SARS-CoV-2 in hospitals under siege.
32661393 2020. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.
32704094 2020. LY6E impairs coronavirus fusion and confers immune control of viral disease.
32669681 2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
32717743 2020. Longitudinal analyses reveal immunological misfiring in severe COVID-19.
32668444 2020. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
32659783 2020. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
32661414 2020. A race to determine what drives COVID-19 severity.
32684080 2020. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
32659199 2020. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
32654247 2020. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.
32672025 2020. Immunite cellulaire contre SARS-CoV-2 : substrat de l'immunite croisee entre coronavirus saisonniers et SARS-CoV-2 ?
32686248 2020. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.
32671966 2020. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
32656939 2020. Lessons from dermatology about inflammatory responses in Covid-19.
32668509 2020. Variabilidad genetica y epigenetica, y la pandemia de Covid-19.
32697854 2020. Interferon: the invisible link between COVID-19 and BCGitis female protection?
32697367 2020. inverted question markAre Superantigens the Cause of Cytokine Storm and viral sepsis in Severe COVID-19? Observations and hypothesis.
32680954 2020. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.
32669287 2020. Comprehensive mapping of immune perturbations associated with severe COVID-19.
32651212 2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.


32679910 2020. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.
32678072 2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.
32694615 2020. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.
32715628 2020. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?
32715618 2020. The protein expression profile of ACE2 in human tissues.
32669467 2020. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
32694127 2020. COVID-19 and the Gut Microbiome: More than a Gut Feeling.
32681106 2020. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
32665645 2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
32686754 2020. Antibody responses to SARS-CoV-2 short-lived.
32686753 2020. Virus dissociated from inflammation in fatal COVID-19.
32651570 2020. CRISPRing for host genes regulating SARS-CoV-2.
32651569 2020. SARS-CoV-2 on the neural battleground.
32651568 2020. T cell renaissance in COVID-19.
32690876 2020. Can COVID-19 strike twice?
32699357 2020. COVID-19 management in light of the circadian clock.
32668692 2020. Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.
32691391 2020. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.
32665786 2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
32685291 2020. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.
32659343 2020. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
32671793 2020. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.
32651900 2020. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology.
32611518 2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
32704472 2020. Hemophagocytic syndrome and COVID-19.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
32704018 2020. Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames.
32691370 2020. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.
32702413 2020. Multisystem Inflammatory Syndrome in Children: Is There a Linkage to Kawasaki Disease?
32653566 2020. Understanding The Complex Relationship Between Androgens and SARS-CoV2.
32679691 2020. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.
32666230 2020. Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.
32699972 2020. Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19.
32687861 2020. Phylogenetic and phylodynamic analyses of SARS-CoV-2.
32674515 2020. Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.
32614178 2020. Pulmonary Edema in COVID19-A Neural Hypothesis.
32638079 2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.
32628642 2020. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.
32650004 2020. Eicosanoids: the Overlooked Storm in COVID-19?
32628931 2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32639866 2020. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.
32622243 2020. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.
32611313 2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
32629042 2020. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.
32646930 2020. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.
32645391 2020. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.
32646523 2020. Adrenomedullin in COVID-19 induced endotheliitis.
32643351 2020. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.
32640417 2020. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
32610564 2020. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.
32646736 2020. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.
32650275 2020. Reappearance of effector T cells is associated with recovery from COVID-19.
32629393 2020. Illuminating COVID-19 lung disease through autopsy studies.
32632419 2020. Eosinopenia and COVID-19 patients: So specific ?
32633718 2020. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
32614767 2020. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.
32618497 2020. High neutralizing antibody titer in intensive care unit patients with COVID-19.
32620946 2020. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
32615182 2020. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
32634438 2020. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.
32631841 2020. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.
32631838 2020. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.
32631836 2020. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?
32646049 2020. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.
32646047 2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
32645523 2020. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.
32640274 2020. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.
32641873 2020. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.
32621172 2020. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.
32615316 2020. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
32622082 2020. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
32638151 2020. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.
32634585 2020. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.
32613447 2020. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.
32630032 2020. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.
32629995 2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.
32645951 2020. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.
32640747 2020. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.
32621017 2020. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.
32642784 2020. Serum antibody response in critically ill patients with COVID-19.
32624257 2020. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
32615258 2020. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.
32639084 2020. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
32634129 2020. Kinetics of viral load and antibody response in relation to COVID-19 severity.
32610587 2020. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.
32635302 2020. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.
32645361 2020. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.
32615199 2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.
32622905 2020. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.
32614392 2020. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.
32647285 2020. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.
32645344 2020. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.
32645661 2020. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?
32645660 2020. Is macrophages heterogeneity important in determining COVID-19 lethality?
32650197 2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
32645659 2020. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.
32646911 2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.
32646908 2020. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.
32641700 2020. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
32641705 2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.
32648040 2020. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.
32642842 2020. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.
32627524 2020. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.
32650002 2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32631071 2020. COVID-ARDS Clarified: A Vascular Endotype?
32649217 2020. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.
32608999 2020. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.
32628534 2020. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.
32633104 2020. Covid-19 related IgA vasculitis.
32636189 2020. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.
32643798 2020. Tackling COVID-19 infection through complement-targeted immunotherapy.
32640169 2020. Potential impact of SARS-CoV-2 infection on the thymus.
32641195 2020. Reply to the letter concerning Kawasaki Disease and Covid-19.
32638018 2020. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
32636454 2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
32639942 2020. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
32639941 2020. The early antibody response to SARS-Cov-2 infection.
32638022 2020. Direct evidence of active SARS-CoV-2 replication in the intestine.
32645713 2020. Microbiota and Covid-19. Which came first, the chicken or the egg?
32645228 2020. Angiotensin II Receptors - Impact for COVID-19 Severity.
32631463 2020. COVID-19: Yin and Yang and Herd Immunity.
32645207 2020. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.
32635753 2020. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32614086 2020. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.
32629518 2020. Inflammatory Cell Infiltration of Adrenals in COVID-19.
32643416 2020. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.
32615317 2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
32624498 2020. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.
32643586 2020. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.
32639183 2020. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.
32640487 2020. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.
32644266 2020. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
32644223 2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
32639581 2020. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.
32633840 2020. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).
32633815 2020. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.
32642770 2020. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.
32640066 2020. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.
32641486 2020. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
32622377 2020. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
32611256 2020. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.
32640127 2020. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.
32641847 2020. A COVID-19 model.
32647358 2020. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
32647346 2020. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
32616673 2020. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
32638509 2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.


32611670 2020. Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues.
32627126 2020. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
32641482 2020. LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
32622376 2020. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
32619412 2020. Endothelial cells orchestrate COVID-19 coagulopathy.
32619411 2020. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
32616514 2020. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.
32629204 2020. A hypothesis on the role of the human immune system in covid-19.
32622045 2020. Integrated Approaches to Reveal Mechanisms by which RNA Viruses Reprogram the Cellular Environment.
32616647 2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco.
32616644 2020. Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019.
32620916 2020. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection.
32632085 2020. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
32612128 2020. High-altitude populations need special considerations for COVID-19.
32636479 2020. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
32636475 2020. SARS-CoV-2-specific T cells without antibodies.
32629960 2020. Evidence for SARS-CoV-2 Infection of Animal Hosts.
32640525 2020. Molecular Aspects of COVID-19 Differential Pathogenesis.
32627515 2020. Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.
32638966 2020. Immunological aspects of coronavirus disease during pregnancy: an integrative review.
32621057 2020. The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.
32616709 2020. Mapping the T cell response to COVID-19.
32619819 2020. S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study.
32615987 2020. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.


C7568207 ?. Síndrome inflamatorio multisistémico en niños con COVID-19: una visión desde la reumatología.
C7561343 ?. Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes?.
C7544460 2020. Caractériser la réponse immunitaire au cours de la pneumopathie grave.
C7577707 ?. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
C7548726 2020. PROTECTIVE FACTORS AGAINST THE COVID-19 STORM.
C7548724 2020. COVID-19 AND A HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-LIKE SYNDROME IN THE ABSENCE OF ARDS.
C7548599 2020. CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME.
C7548549 2020. SECONDARY HLH PRESENTING AS ARDS.


33330852 2021. Unfolded protein response in the COVID-19 context.
33123500 2020. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.
33095394 2020. Multisystem Inflammatory Syndrome in Children: A Mimicker of Severe Dengue.
33228920 2020. Herd immunity confusion.
33031752 2020. MIS-C: post-infectious syndrome or persistent infection?


33484168 2021. Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19.
33399182 2021. Herd Immunity to COVID-19.
33469560 2021. Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS).
33521168 2020. Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications.
33406838 2021. N- and O-Glycosylation of the SARS-CoV-2 Spike Protein.
33458987 2021. Sindrome inflamatorio multisistemico en ninos, relacionado con COVID-19: actualizacion a proposito de la presentacion de 2 pacientes criticos.
33458972 2021. Tormenta de citoquinas y tormenta de informacion asociadas a COVID-19: consideraciones sobre el sindrome inflamatorio multisistemico en ninos.
33398692 2021. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.
33483791 2021. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.
33464421 2021. Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations.
33462671 2021. The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.
33521335 2021. The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve.
33506114 2021. Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan.
33515911 2021. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
33413979 2021. A nidovirus perspective on SARS-CoV-2.
33450483 2021. The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.
33484784 2021. Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2.
33445785 2021. The Long-Term Evolutionary History of Gradual Reduction of CpG Dinucleotides in the SARS-CoV-2 Lineage.
33486617 2021. NMR assignments of the macro domain from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
33484403 2021. (1)H, (13)C and (15)N chemical shift assignment of the stem-loop 5a from the 5'-UTR of SARS-CoV-2.
33475934 2021. (1)H, (13)C and (15)N backbone chemical shift assignments of SARS-CoV-2 nsp3a.
33423172 2021. (1)H,(13)C and (15)N chemical shift assignments of the SUD domains of SARS-CoV-2 non-structural protein 3c: "The SUD-M and SUD-C domains".
33392924 2021. Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - mus) dynamics in the C-terminal helix at the dimer interface.
33389548 2021. (1)H, (15)N and (13)C resonance assignments of the N-terminal domain of the nucleocapsid protein from the endemic human coronavirus HKU1.
33504682 2021. Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection.
33484712 2021. Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein.
33460600 2021. Improving SARS-CoV-2 structures: Peer review by early coordinate release.
33401144 2021. Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-kappaB p50 as the regulator of cytokine storm.
33407800 2021. Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2.
33419930 2021. What are SARS-CoV-2 genomes from the WHO Africa region member states telling us?
33479725 2021. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome.
33491070 2021. Noncoding RNAs: modulators and modulatable players during infection-induced stress response.
33405097 2021. SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation.
33448856 2021. Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches.
33426894 2021. NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.
33426872 2021. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
33400372 2021. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
33485447 2021. Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
33485446 2021. Neuropathology associated with SARS-CoV-2 infection.
33485445 2021. Neuropathology associated with SARS-CoV-2 infection.
33485444 2021. Neuropathology associated with SARS-CoV-2 infection.
33453781 2021. Using EM data to understand COVID-19 pathophysiology - Authors' reply.
33453779 2021. Using EM data to understand COVID-19 pathophysiology.
33450180 2021. First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020.
33417829 2021. New variant of SARS-CoV-2 in UK causes surge of COVID-19.
33392518 2021. SARS-CoV-2 serological cross-reactivity with autoantibodies - Authors' reply.
33392517 2021. SARS-CoV-2 serological cross-reactivity with autoantibodies.
33454368 2021. Monocytes and macrophages in COVID-19: Friends and foes.
33453245 2021. The proteomic characteristics of airway mucus from critical ill COVID-19 patients.
33508291 2021. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.
33468702 2021. SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.
33468697 2021. Atypical Divergence of SARS-CoV-2 Orf8 from Orf7a within the Coronavirus Lineage Suggests Potential Stealthy Viral Strategies in Immune Evasion.
33468695 2021. SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike.
33436436 2021. Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity?
33511329 2020. Adhesive contact between cylindrical (Ebola) and spherical (SARS-CoV-2) viral particles and a cell membrane.
33412501 2021. Polycations and polyanions in SARS-CoV-2 infection.
33505220 2021. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.
33414350 2021. Genomic Sequences and Analysis of Five SARS-CoV-2 Variants Obtained from Patients in Lambayeque, Peru.
33414330 2021. Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates.
33414329 2021. Genome Sequences of Two GH Clade SARS-CoV-2 Strains Isolated from Patients with COVID-19 in South Korea.
33509997 2021. Genome Sequence of a SARS-CoV-2 VUI 202012/01 Strain Identified from a Patient Returning from London, England, to the Apulia Region of Italy.
33509993 2021. Genome Sequences of 10 SARS-CoV-2 Viral Strains Obtained by Nanopore Sequencing of Nasopharyngeal Swabs in Malta.
33509990 2021. Genome Sequencing of a Novel Coronavirus SARS-CoV-2 Isolate from Iraq.
33479004 2021. Expression of Concern for Sah et al., "Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal".
33401565 2021. SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients.
33445583 2021. Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers.
33476315 2021. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
33386849 2021. Population dynamics and structural effects at short and long range support the hypothesis of the selective advantage of the G614 SARS-Cov2 spike variant.
33417854 2021. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.
33444546 2021. Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.
33474931 2021. Topography, Spike Dynamics, and Nanomechanics of Individual Native SARS-CoV-2 Virions.
33420022 2021. Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.
33397909 2021. Neutralizing antibody titres in SARS-CoV-2 infections.
33397903 2021. Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.
33504779 2021. Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics.
33483492 2021. SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.
33479198 2021. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein.
33431842 2021. Stabilizing the closed SARS-CoV-2 spike trimer.
33402727 2021. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
33442033 2021. What have we learnt so far from COVID-19?
33432128 2021. Super(antigen) target for SARS-CoV-2.
33425367 2021. A single nucleotide distinguishes the SARS-CoV-2 in the Wuhan outbreak in December 2019 from that in Beijing-Xinfadi in June 2020, China.
33398006 2021. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses.
33381273 2020. SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?
33391390 2021. SARS-CoV-2 paediatric inflammatory syndrome.
33479801 2021. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.
33437273 2021. Real-Time Polymerase chain reaction trends in COVID-19 patients.
33401530 2021. SARS-CoV-2-Cholesterol Interaction: A Lot of Food for Thought.
33428826 2021. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis.
33433671 2021. Extracardiac imaging findings in COVID-19-associated multisystem inflammatory syndrome in children.
33404786 2021. Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19.
33505806 2021. Identification and molecular characterization of mutations in nucleocapsid phosphoprotein of SARS-CoV-2.
33391880 2020. Full-length genome characterization and phylogenetic analysis of SARS-CoV-2 virus strains from Yogyakarta and Central Java, Indonesia.
33384909 2020. Mutational spectra of SARS-CoV-2 isolated from animals.
33382773 2020. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.
33382764 2020. Antibody response to SARS-CoV-2 infection in humans: A systematic review.
33382687 2020. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
33507952 2021. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.
33493182 2021. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.
33476327 2021. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
33465137 2021. The coronavirus proofreading exoribonuclease mediates extensive viral recombination.
33411764 2021. Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.
33395426 2021. The role of Neuropilin-1 in COVID-19.
33399747 2020. Sindrome inflamatorio multisistemico asociado con SARS-CoV-2 en pediatria.
33399746 2020. Sindrome inflamatorio multisistemico temporal asociado con SARS-CoV-2 pediatrico: inverted question markComo nos enfrentamos a un enemigo impredecible?
33411967 2021. Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma.
33414185 2021. Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'.
33414184 2021. Response to: 'Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm by Tampe et al.
33446481 2021. Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds.
33380408 2020. Covid-19: Antibodies protect against reinfection for at least six months, study finds.
33464010 2021. COVID-19-Related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn.
33414238 2021. Inflammatory Bowel Disease Presenting With Concurrent COVID-19 Multisystem Inflammatory Syndrome.


33505752 2021. COVID-19-Associated Multisystem Inflammatory Syndrome Complicated with Giant Coronary Artery Aneurysm.
33382968 2021. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.
33412089 2021. COVID-19-neutralizing antibodies predict disease severity and survival.
33497610 2021. Adaptive immunity to SARS-CoV-2 and COVID-19.
33516131 2021. Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2.
33441142 2021. On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.
33500559 2021. Antibodies, epicenter of SARS-CoV-2 immunology.
33510134 2021. N(6)-methyladenosine regulates RNA abundance of SARS-CoV-2.
33479219 2021. SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation into stress granules through its N-terminal intrinsically disordered region.
33388094 2021. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.
33483707 2021. Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients.
33473190 2021. Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response.
33420358 2021. Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.
33420356 2021. The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity.
33408342 2021. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.
33449149 2021. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release.
33503420 2021. The immunodominant and neutralization linear epitopes for SARS-CoV-2.
33440148 2021. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.
33417835 2021. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.
33485405 2021. Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD.
33500101 2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
33495758 2021. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.
33495757 2021. Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19.
33495756 2021. Use of machine learning to identify a T cell response to SARS-CoV-2.
33420426 2021. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.
33450186 2021. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.
33518776 2020. Computed optical spectra of SARS-CoV-2 proteins.
33445833 2021. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019.
33417689 2021. Lack of SARS-CoV2 neutralization by antibodies to seasonal coronaviruses: making sense of the COVID-19 pandemic.
33400782 2021. The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.
33395482 2021. SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.
33388756 2021. Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany.
33501951 2021. Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
33501950 2021. Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.
33386403 2021. SARS-CoV-2 immunity and reinfection.
33479086 2021. Lessons of the month: A misunderstood teenager with paediatric inflammatory multisystem syndrome - temporarily associated with SARS-CoV-2 admitted under adult medicine.
33524589 2021. A global analysis of replacement of genetic variants of SARS-CoV-2 in association with containment capacity and changes in disease severity.
33482352 2021. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study.
33465499 2021. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient.
33450388 2021. Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays.
33484220 2021. Development of a SARS-CoV-2 rapid antibody detection kit and study on dynamic changes in antibodies in infected patients.
33389315 2021. Haemophagocytic syndrome and COVID-19.
33520118 2021. Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.
33506994 2021. Different hair loss patterns in two pediatric patients with COVID-19-associated multisystem inflammatory syndrome in children.
33522642 2021. Syncytia formation by SARS-CoV-2-infected cells.
33522893 2021. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
33401657 2021. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.
33497356 2021. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
33492309 2021. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.
33427749 2021. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
33467466 2021. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It.
33399879 2021. Production of ORF8 protein from SARS-CoV-2 using an inducible virus-mediated expression system in suspension-cultured tobacco BY-2 cells.
33465066 2021. Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers.
33411735 2021. COVID-19, leprosy, and neutrophils.
33513195 2021. High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration.
33507994 2021. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
33497392 2021. Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains.
33493185 2021. T cell response to SARS-CoV-2 infection in humans: A systematic review.
33479167 2021. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
33446512 2021. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
33406522 2021. Genetic Variation and Evolution of the 2019 Novel Coronavirus.
33460776 2021. Can efficient stimulation of myogenic microcirculatory oscillations by transient ischemia predict low incidence of COVID-19 infection?
33472605 2021. Plasma microbial cell-free DNA load is associated with mortality in patients with COVID-19.
33495715 2021. SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production.
33495714 2021. Binding of the SARS-CoV-2 Spike Protein to Glycans.
33420163 2021. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.
33510359 2021. Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.
33510353 2021. Network theoretic analysis of JAK/STAT pathway and extrapolation to drugs and viruses including COVID-19.
33510275 2021. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
33504824 2021. Altered high-density lipoprotein composition and functions during severe COVID-19.
33500507 2021. CD8(+) T cells predicted the conversion of common covid-19 to severe.
33479465 2021. SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.
33432067 2021. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
33514692 2021. Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA.
33514685 2021. Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection.
33462185 2021. Not only ACE2-the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19.
33431822 2021. Connections between biomechanics and higher infectivity: a tale of the D614G mutation in the SARS-CoV-2 spike protein.
33381288 2020. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment.
33437929 2021. Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement-A Scoping Review.
33432304 2021. Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis.
33426471 2021. Is Eye Immune-Privileged to COVID-19 Infection?
33403490 2021. Does the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body?
33500718 2021. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
33391477 2021. Immunopathogenesis and treatment of cytokine storm in COVID-19.
33457321 2020. Can we Turn off the "Covid-Biting-Tail" Inflammation?
33455862 2021. Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19.
33451855 2021. Dysregulation of Cell Signaling by SARS-CoV-2.
33467724 2021. Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.
33440622 2021. SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region.
33413449 2021. Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling.
33450669 2021. Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.
33387787 2021. Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target.
33500788 2021. Synonymous mutations and the molecular evolution of SARS-CoV-2 origins.
33500787 2021. Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink.
33476695 2021. The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
33418027 2021. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).
33499234 2021. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy.
33498225 2021. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein.
33477951 2021. Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients.
33477885 2021. Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.
33467206 2021. MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species.
33440724 2021. The Fatty Acid Lipid Metabolism Nexus in COVID-19.
33396605 2020. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-beta Production.
33419245 2020. Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization?
33392306 2020. Virus load and virus shedding of SARS-CoV-2 and their impact on patient outcomes.
33410308 2021. Pitfalls of barcodes in the study of worldwide SARS-CoV-2 variation and phylodynamics.
33389884 2020. Immune Computation and COVID-19 Mortality: A Rationale for IVIg.
33494667 2021. Role of Poly(ADP-ribose) polymerase (PARP1) in viral infection and its implication in SARS-CoV-2 pathogenesis.
33394725 2021. Editorial: Do not lose focus on myeloid biology in the era of COVID-19.
33434935 2021. Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs.
33479166 2021. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
33472860 2021. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.


33432808 2021. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin.
33458462 2021. Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis.
33489438 2020. An unorthodox pathophysiology of severe cases of COVID-19 the weak heme hypothesis.
33434105 2021. SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport.
33434104 2021. Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality.
33416946 2021. Are all cytokine storms the same?
33407957 2021. Junctional tachycardia due to multisystem inflammatory syndrome in children with SARS-CoV-2 infection in a 12-year-old female.
33516277 2021. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
33521695 2021. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.
33387094 2021. Kawasaki disease and influenza-new lessons from old associations.
33428101 2021. Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic.
33411143 2021. COVID-19, rheumatic diseases and immune dysregulation-a perspective.
33456620 2021. Principal Component Analysis Applications in COVID-19 Genome Sequence Studies.
33514825 2021. SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus.
33383528 2021. Identification and computational analysis of mutations in SARS-CoV-2.
33456724 2021. Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic beta-CoVs.
33425248 2021. Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes.
33391633 2021. Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?
33397460 2021. Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome.
33403180 2020. Adult Inflammatory Multi-System Syndrome Mimicking Kawasaki Disease in a Patient With COVID-19.
33425537 2020. A Case of Multisystem Inflammatory Syndrome Post-COVID-19 Infection in an Adult.
33457109 2021. Decoding Covid-19 with the SARS-CoV-2 Genome.
33508651 2021. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?
33487779 2020. Genomic Study of COVID-19 Corona Virus Excludes Its Origin from Recombination or Characterized Biological Sources and Suggests a Role for HERVS in Its Wide Range Symptoms.
33522107 2021. Sustained cellular immunity in adults recovered from mild COVID-19.
33496367 2021. A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19.
33422265 2021. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation.
33436069 2021. Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus.
33388575 2021. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.
33520333 2020. Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity.
33427152 2021. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children.
33517929 2021. Diversity of SARS-CoV-2 isolates driven by pressure and health index.
33462598 2021. COVID 19: in the eye of the cytokine storm.
33404891 2021. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
33421274 2021. Circulating cardiovascular microRNAs in critically ill COVID-19 patients.
33452570 2021. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
33419887 2021. Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia.
33506945 2021. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.
33478625 2021. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020.
33495994 2021. Is lymphopenia different between SARS and COVID-19 patients?
33503469 2021. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between alpha7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.
33510633 2020. Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases.
33520952 2020. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.
33521069 2020. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19.
33505977 2020. Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.
33392109 2020. Is the "Common Cold" Our Greatest Ally in the Battle Against SARS-CoV-2?
33511102 2020. Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences.
33469527 2020. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations.
33381492 2020. Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins.
33488517 2020. The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection.
33519902 2020. Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles.
33505425 2020. Deciphering the Subtype Differentiation History of SARS-CoV-2 Based on a New Breadth-First Searching Optimized Alignment Method Over a Global Data Set of 24,768 Sequences.
33424918 2020. A Comprehensive Analysis of cis-Acting RNA Elements in the SARS-CoV-2 Genome by a Bioinformatics Approach.
33519814 2020. Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury.
33519802 2020. Does Angiotensin II Peak in Response to SARS-CoV-2?
33424856 2020. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
33391280 2020. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
33384691 2020. Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.
33392257 2020. Surveying the Side-Chain Network Approach to Protein Structure and Dynamics: The SARS-CoV-2 Spike Protein as an Illustrative Case.
33469522 2020. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.
33425823 2020. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment.
33381049 2020. A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface.
33510644 2020. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
33414726 2020. Physiology of Midkine and Its Potential Pathophysiological Role in COVID-19.
33392612 2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Codon Usage and Replicative Fitness.
33403225 2020. SARS-CoV-2: A Trigger for Kawasaki Disease or a New Syndrome?
33431578 2021. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
33495741 2021. Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa.
33437888 2021. Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis.
33524881 2021. What do we know about the antibody responses to SARS-CoV-2?
33427136 2021. The 501.V2 and B.1.1.7 variants of coronavirus disease 2019 (COVID-19): A new time-bomb in the making?
33521603 2021. A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity.
33521593 2021. The presentation of SARS-CoV-2 peptides by the common HLA-A( )02:01 molecule.
33480287 2021. Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic.
33506741 2021. Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis.
33513242 2021. Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia.
33524125 2021. Post Convalescent SARS-CoV-2 IgG and Neutralizing Antibodies Are Elevated in Individuals with Poor Metabolic Health.
33464307 2021. Mapping and role of T cell response in SARS-CoV-2-infected mice.
33431260 2021. Reply to letter to the editor: Kawasaki disease and COVID-19: A pretext for a hot topic.
33464637 2021. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
33512021 2021. Evolutionary analysis of SARS-CoV-2 spike protein for its different clades.
33506970 2021. Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID-19?
33506952 2021. Role of Toll-like receptors in the pathogenesis of COVID-19.
33506951 2021. Emergence of SARS-CoV-2 Variant: A wake-up call for Pakistan's overburdened healthcare system.
33506950 2021. Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia.
33506962 2021. A parsimonious approach for recognizing SARS-CoV-2 and host interactions.
33433004 2021. Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.
33427302 2021. Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.
33493263 2021. Kidney injury molecule-1 is a potential receptor for SARS-CoV-2.
33453103 2021. Kidney injury molecule-1: a novel entry factor for SARS-CoV-2.
33518219 2020. Compelling evidence of a novel multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection.
33458751 2021. 16 Weeks Later: Expanding the Risk Period for MIS-C.
33500262 2021. Covid-19: New UK variant may be linked to increased death rate, early data indicate.
33380449 2021. Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection.
33504377 2021. Coronary aneurysms, myocardial dysfunction, and shock in a COVID-19 child, role of ECMO, immunomodulation, and cardiac CT.
33382348 2021. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?
33510385 2021. The m(6)A methylome of SARS-CoV-2 in host cells.
33394568 2021. Illuminating the immunopathology of SARS-CoV-2.
33504318 2021. An Alternative "Trojan Horse" Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology.
33499661 2021. RNA editors: key regulators of viral response in cancer patients.
33467896 2021. Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins A new frontier.
33435808 2021. Immune memory: an evolutionary perspective.
33417561 2021. Detection of Phenotype-related Mutations of COVID-19 via the Whole Genomic Data.
33444511 2021. Immune response to COVID-19 infection: a double-edged sword.
33443384 2021. What Is a Cytokine Storm and Should It Matter to Me?
33412850 2021. Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion.
33427605 2021. A genetic element in the SARS-CoV-2 genome is shared with multiple insect species.
33506974 2021. Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and common respiratory pathogens in COVID-19 patients.
33458832 2021. World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype.
33386744 2021. The dilemma of herd immunity for COVID-19.
33404091 2021. In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans.
33510530 2021. Kawasaki Disease like Multisystem Inflammatory Syndrome in a Toddler during SARS-CoV-2 Pandemic in Nepal.


33399535 2021. Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection.
33393462 2021. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site.
33443016 2021. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2.
33496249 2021. Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020.
33496647 2021. Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.
33407005 2021. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.
33399033 2021. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France.
33399028 2021. The interplay between emerging human coronavirus infections and autophagy.
33422505 2021. Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung.
33478621 2021. Updated rapid risk assessment from ECDC on the risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update.
33413740 2021. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.
33400927 2021. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
33504359 2021. Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients.
33444084 2021. Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children.
33382362 2021. Changes of peripheral lymphocyte subset in patients with SARS-CoV-2 infection during the whole course of disease.
33500774 2020. Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity.
33456761 2020. SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets.
33391730 2020. 'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients.
33467912 2021. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).
33484691 2021. Reply: Dysbiosis in SARS-CoV-2 infected patients.
33387514 2020. Dysbiosis in SARS-CoV-2 infected patients.
33398248 2021. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways.
33521382 2021. Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes.
33490718 2021. Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 pandemic.
33521384 2020. Genetic variations among SARS-CoV-2 strains isolated in China.
33503821 2021. Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates.
33396837 2020. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene at the Population-Level.
33521209 2020. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.
33395363 2021. Epigenetic mechanisms influencing COVID-19.
33512495 2021. Rapid Spread of Mutant Alleles in Worldwide SARS-CoV-2 Strains Revealed by Genome-Wide Single Nucleotide Polymorphism and Variation Analysis.
33383142 2021. Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing.
33412761 2020. Updated confidence intervals for the COVID-19 antibody retention rate in the Korean population.
33412760 2020. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.
33390179 2021. Alu retrotransposons and COVID-19 susceptibility and morbidity.
33406391 2021. T Cell Memory: Understanding COVID-19.
33382973 2021. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
33513337 2021. B cell memory: understanding COVID-19.
33428993 2021. Did we forget the diffuse chemosensory system when studying COVID-19?
33421440 2021. Immune reactivity during COVID-19: Implications for treatment.
33400966 2021. Are the emerging SARS-COV-2 mutations friend or foe?
33384516 2020. Multisystem Inflammatory Syndrome in Children: Clinical Features and Management-Intensive Care Experience from a Pediatric Public Hospital in Western India.
33384501 2020. Multisystem Inflammatory Syndrome of Children Related to SARS-CoV-2: A Novel Experience in Children with a Novel Virus.
33446986 2020. COVID-19-associated Severe Multisystem Inflammatory Syndrome in Children with Encephalopathy and Neuropathy in an Adolescent Girl with the Successful Outcome: An Unusual Presentation.
33403611 2021. COVID-19 in a Young Infant - A Fatal Multisystem Inflammatory Disorder.
33508515 2021. Association of clade-G SARS-CoV-2 viruses and age with increased mortality rates across 57 countries and India.
33513449 2021. Different SARS-CoV-2 haplotypes associate with geographic origin and case fatality rates of COVID-19 patients.
33516969 2021. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2.
33476804 2021. Clade GR and clade GH isolates of SARS-CoV-2 in Asia show highest amount of SNPs.
33387262 2021. Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain.
33385239 2021. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.
33521758 2020. From Animal to Human: Interspecies Analysis Provides a Novel Way of Ascertaining and Fighting COVID-19.
33498051 2021. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.
33486489 2021. SARS-CoV-2-Associated T-Cell Responses in the Presence of Humoral Immunodeficiency.
33440306 2021. An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses.
33401205 2021. The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.
33385714 2021. Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity.
33450373 2021. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.
33430309 2021. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
33430234 2021. Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions.
33498725 2021. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.
33498183 2021. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
33396557 2020. Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus.
33396899 2020. Role of Host-Mediated Post-Translational Modifications (PTMs) in RNA Virus Pathogenesis.
33433784 2021. A Novel Protein Mapping Method for Predicting the Protein Interactions in COVID-19 Disease by Deep Learning.
33386601 2021. Two different patterns of lymphocyte alterations in critically ill COVID-19 patients.
33454715 2021. Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets.
33463113 2020. Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.
33463127 2020. COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis.
33437935 2021. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections.
33421631 2021. Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword.
33388272 2020. Dynamics of severe acute respiratory syndrome coronavirus 2 genome variants in the feces during convalescence.
33493496 2021. Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.
33472093 2021. Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
33406394 2021. Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.
33383088 2021. Emergence of a new SARS-CoV-2 variant in the UK.
33487533 2021. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
33411935 2021. Early differences in cytokine production distinguish severity of COVID-19.
33502532 2021. Role of cell adhesion molecules for disease development of patients with and without COVID-19 in the emergency department.
33493287 2021. Monocytes and macrophages, targets of SARS-CoV-2: the clue for Covid-19 immunoparalysis.
33476387 2021. Immune profiling reveals early disease trajectories associated with COVID-19 mortality: a sub-study from the ACTT-1 trial.
33433587 2021. Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19.
33524124 2021. Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19.
33524110 2021. Increased PD-L1 expression may be associated with the cytokine storm and CD8 + T-cell exhaustion in severe COVID-19.
33519225 2021. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms.
33432259 2021. Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species.
33429476 2021. The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children.
33506254 2021. Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis.
33513240 2021. Unusual Clinical Manifestations and Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C) in a Tertiary Care Hospital of North India.
33518372 2021. Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient.
33521734 2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.
33521726 2020. Immunogenomic phases of COVID-19 and appropriate clinical management.
33521749 2021. Cell-Free DNA Tissues-of-Origin by Methylation Profiling Reveals Significant Cell, Tissue and Organ-Specific injury related to COVID-19 Severity.
33521750 2020. Vaccination Is the Only Acceptable Path to Herd Immunity.
33521315 2021. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.
33427554 2021. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases.
33514928 2021. Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
33423311 2021. Human SARS CoV-2 spike protein mutations.
33415739 2021. Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus.
33380494 2021. Coronavirus Receptors as Immune Modulators.
33514628 2021. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.
33523115 2021. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
33404586 2021. Genetic Variants of SARS-CoV-2-What Do They Mean?
33393161 2021. Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins.
33432184 2021. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.
33442016 2021. Immune determinants of COVID-19 disease presentation and severity.
33402708 2021. Cold sensitivity of the SARS-CoV-2 spike ectodomain.
33494095 2021. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
33461210 2021. Evolution of antibody immunity to SARS-CoV-2.
33479534 2021. Fast-spreading COVID variant can elude immune responses.
33473223 2021. Lessons from the host defences of bats, a unique viral reservoir.
33469239 2021. The world needs a single naming system for coronavirus variants.
33429418 2021. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.


33515497 2021. Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care Community.
33400131 2021. European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients.
33401171 2021. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
33476648 2021. SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis.
33434581 2020. The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles.
33475020 2021. Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study.
33459964 2021. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
33394320 2021. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France.
33387156 2021. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
33402024 2021. Computational analysis of dynamic allostery and control in the SARS-CoV-2 main protease.
33383190 2021. Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2.
33508323 2021. Latent periodicity-2 in coronavirus SARS-CoV-2 genome: Evolutionary implications.
33413461 2021. Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients.
33413422 2021. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
33380328 2020. Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.
33513380 2021. Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
33448184 2021. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
33497357 2021. Distinct antibody repertoires against endemic human coronaviruses in children and adults.
33476301 2021. Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19.
33497425 2021. Isolating SARS-CoV-2 Strains From Countries in the Same Meridian: Genome Evolutionary Analysis.
33496683 2020. The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.
33518995 2021. Threats from new variants.
33519006 2021. The coronavirus could end up mild like a common cold.
33519005 2021. The global threat of the coronavirus variants.
33519003 2021. What are the new coronavirus variants?
33521378 2021. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19.
33512464 2021. How can we interpret SARS-CoV-2 antibody test results?
33469663 2021. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
33493353 2021. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: A French study and literature review.
33519278 2021. Genome composition and genetic characterization of SARS-CoV-2.
33519271 2021. Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19.
33482019 2021. An increase in CD62L(dim) neutrophils precedes the development of pulmonary embolisms in COVID-19 patients.
33523532 2021. Early humoral defence: Contributing to confining COVID-19 to conducting airways?
33521857 2021. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.
33443036 2020. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
33436498 2021. Cytoplasmic short linear motifs in ACE2 and integrin beta3 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy.
33436497 2021. Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications.
33408181 2021. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
33436525 2021. Immunological characteristics govern the transition of COVID-19 to endemicity.
33419936 2021. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK.
33421326 2021. First genome sequencing of SARS-CoV-2 recovered from an infected cat and its owner in Latin America.
33506644 2021. Genotype-phenotype correlation identified a novel SARS-CoV-2 variant possibly linked to severe disease.
33501730 2021. A deletion in SARS-CoV-2 ORF7 identified in COVID-19 outbreak in Uruguay.
33452828 2021. Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.
33524849 2021. Coronavirus infection induces progressive restructuring of the endoplasmic reticulum involving the formation and degradation of double membrane vesicles.
33494661 2021. COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.
33469204 2021. Rogue antibodies could be driving severe COVID-19.
33478949 2021. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells.
33510015 2021. Insights from SARS-CoV-2 sequences.
33446556 2021. Learning the language of viral evolution and escape.
33446540 2021. Herd immunity by infection is not an option.
33484868 2021. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.
33443366 2021. Severe COVID-19: Immunosuppression or Hyperinflammation?
33481684 2021. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
33423443 2021. [Immunological research of COVID-19 and emerging infectious diseases].
33685917 2021. The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
33727331 2021. Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
33649194 2021. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
33637603 2021. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.


33784032 2021. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Rapid Living Review
33745765 2021. Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat.
33656515 2021. Immunodominant antibody germlines in COVID-19.
33646265 2021. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
33739364 2021. Lasting memories of SARS-CoV-2 infection.
33533916 2021. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
33533915 2021. Persistent cellular immunity to SARS-CoV-2 infection.
33707363 2021. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
33721886 2021. Adaptive metabolic and inflammatory responses identified using accelerated aging metrics are linked to adverse outcomes in severe SARS-CoV-2 infection.
33528568 2021. The Nexus between Telomere Length and Lymphocyte Count in Seniors hospitalized with Covid-19.
33766545 2021. SARS-CoV-2 mutational variants may represent a new challenge to society, but not to the virucidal armamentarium.
33644235 2021. Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population.
33707314 2021. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.
33581239 2021. Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.
33548358 2021. Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.
33545166 2021. Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
33766552 2021. Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.
33531292 2021. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
33718952 2021. Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days.
33675366 2021. The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers.
33580264 2021. Uncovering Ways That Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Lineages May Increase Transmissibility.
33580259 2021. S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.
33556959 2021. Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age.
33693749 2021. Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2.
33686421 2021. Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19.
33649773 2021. Persistent SARS-CoV-2 RNA Shedding without Evidence of Infectiousness: A Cohort Study of Individuals with COVID-19.
33743370 2021. Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health.
33732005 2021. Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers.
33531826 2021. Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality.
33630386 2021. Remembering Metchnikoff in the time of COVID-19.
33638484 2021. New SARS-CoV-2 variant of concern imported from the United Kingdom to Vietnam, December 2020.
33620098 2021. Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan.
33590900 2021. Anti-spike S1 receptor-binding domain antibodies against SARS-CoV-2 persist several months after infection regardless of disease severity.
33570181 2021. Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.
33638460 2021. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
33624270 2021. A comprehensive review of SARS-CoV-2 genetic mutations and lessons from animal coronavirus recombination in one health perspective.
33623737 2020. Artificial Intelligence in COVID-19 Ultrastructure.
33744314 2021. SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca(2).
33556408 2021. The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins.
33630074 2021. Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction.
33740562 2021. Which species does the virus like most: Binding modes study between SARS-CoV-2 S protein and ACE2 receptor.
33588349 2021. Epitope mimicry analysis of SARS-COV-2 surface proteins and human lung proteins.
33624189 2021. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of (18)F-FDG PET/CT to assess myocardial involvement.
33550983 2021. COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
33640331 2021. Intracranial Hypertension in Multisystem Inflammatory Syndrome in Children.
33713130 2021. Multisystem Inflammatory Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Children: A Case Series From Mayotte Island.
33626315 2021. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
33613009 2021. Aggregation hot spots in the SARS-CoV-2 proteome may constitute potential therapeutic targets for the suppression of the viral replication and multiplication.
33724837 2021. Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses.
33666082 2021. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
33555895 2021. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
33582489 2021. Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.
33662570 2021. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
33532723 2021. Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department.
33693926 2021. SARS-CoV-2 Variant of Concern 202 012/01 (B.1.1.7) in a traveller from the UK to China.
33693754 2021. First Report of SARS-CoV-2 B.1.1.251 lineage in Brazil.
33563656 2021. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
33644276 2021. Two adult cases of multisystem inflammatory syndrome associated with SARS-CoV-2.
33681536 2021. What Are the Clinical Implications of the SARS-CoV-2 Variants: 5 Things Every Cardiologist Should Know.
33782672 2021. Regression of Coronary Aneurysms With Intravenous Immunoglobulins and Steroids for COVID-19 Adult Multisystem Inflammatory Syndrome.
33649746 2021. Reversible Coronary Artery Aneurysm With Delayed Anti-inflammatory Therapy in Multisystem Inflammatory Syndrome in Children.
33625463 2021. Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.
33749770 2021. Association of Age With SARS-CoV-2 Antibody Response.
33674591 2021. Deciphering the state of immune silence in fatal COVID-19 patients.
33785765 2021. SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself.
33782395 2021. The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA.
33771993 2021. N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection.
33767183 2021. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition.
33753738 2021. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.
33741972 2021. Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.
33723254 2021. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication.
33712622 2021. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
33712587 2021. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.
33707453 2021. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.
33563974 2021. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.
33558507 2021. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.
33558493 2021. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.
33547281 2021. Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2.
33619281 2021. Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.
33608522 2021. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.
33597532 2021. Dysregulated transcriptional responses to SARS-CoV-2 in the periphery.
33597531 2021. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.
33589636 2021. Discrete SARS-CoV-2 antibody titers track with functional humoral stability.
33574281 2021. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.
33542501 2021. SARS-CoV-2 variant evades antibodies whilst maintaining fitness.
33542500 2021. Do rogue antibodies make the difference between mild versus severe COVID-19?
33726806 2021. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
33627147 2021. Distinguishing active pediatric COVID-19 pneumonia from MIS-C.
33665043 2021. Low compositions of human toll-like receptor 7/8-stimulating RNA motifs in the MERS-CoV, SARS-CoV and SARS-CoV-2 genomes imply a substantial ability to evade human innate immunity.
33614298 2021. Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study.
33721239 2021. COVID-19 and the ethnicity link - is there a photochemical link?
33687143 2021. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?
33625796 2021. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
33780434 2021. Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium.
33760807 2021. SARS-CoV-2 variants reveal features critical for replication in primary human cells.
33750978 2021. A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
33730024 2021. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
33711012 2021. Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen.
33730053 2021. SARS-CoV-2 viral dynamics in non-human primates.
33534793 2021. ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways.
33793546 2021. Computational epitope map of SARS-CoV-2 spike protein.
33770098 2021. Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel.
33755704 2021. Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.
33750984 2021. Antibody kinetics and clinical course of COVID-19 a prospective observational study.
33730017 2021. Structural analysis of viral ExoN domains reveals polyphyletic hijacking events.
33725024 2021. Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome.
33662015 2021. Genomic characterization and evolution of SARS-CoV-2 of a Canadian population.
33661923 2021. Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.
33685917 2021. The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.
33727331 2021. Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.
33649194 2021. Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.
33637603 2021. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction.


33619452 2021. Rare mutations in the accessory proteins ORF6, ORF7b, and ORF10 of the SARS-CoV-2 genomes.
33662365 2021. The serum metabolome of COVID-19 patients is distinctive and predictive.
33631142 2021. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
33548252 2021. COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?
33750009 2021. COVID-19: emergence and mutational diversification of SARS-CoV-2.
33727169 2021. Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus.
33691172 2021. Contribution of STAT3 to the pathogenesis of COVID-19.
33609650 2021. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
33588026 2021. Variant analysis of SARS-CoV-2 genomes in the Middle East.
33548481 2021. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.
33664151 2021. Identification of a SARS-CoV-2 Lineage B1.1.7 Virus in New York following Return Travel from the United Kingdom.
33766902 2021. Genome Sequences of Three SARS-CoV-2 P.1 Strains Identified from Patients Returning from Brazil to Italy.
33766897 2021. Near-Complete Genome Sequence of a SARS-CoV-2 VOC 202012/01 Strain in Peru.
33737349 2021. First Report of a SARS-CoV-2 Genome Sequence with a Spike His69-Val70 Deletion and an Asn439Lys Mutation in Morocco.
33707329 2021. Coding-Complete Genome Sequences and Mutation Profiles of Nine SARS-CoV-2 Strains Detected from COVID-19 Patients in Bangladesh.
33707325 2021. Coding-Complete Genome Sequence and Phylogenetic Relatedness of a SARS-CoV-2 Strain Detected in March 2020 in Cameroon.
33632859 2021. In-Frame 12-Nucleotide Deletion within Open Reading Frame 3a in a SARS-CoV-2 Strain Isolated from a Patient Hospitalized with COVID-19.
33632858 2021. Genome Sequence of a SARS-CoV-2 Strain from Bangladesh That Is Nearly Identical to United Kingdom SARS-CoV-2 Variant B.1.1.7.
33574104 2021. Coding-Complete Genome Sequences of NITMA1086 and NITMA1139, Two SARS-CoV-2 Isolates from Belagavi District, Karnataka State, India, Harboring the D614G Mutation.
33562210 2021. Silence of the Lambs: The Immunological and Molecular Mechanisms of COVID-19 in Children in Comparison with Adults.
33652815 2021. SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation.
33671631 2021. Genomic Epidemiology of SARS-CoV-2 in Madrid, Spain, during the First Wave of the Pandemic: Fast Spread and Early Dominance by D614G Variants.
33540596 2021. Dynamics of a Dual SARS-CoV-2 Lineage Co-Infection on a Prolonged Viral Shedding COVID-19 Case: Insights into Clinical Severity and Disease Duration.
33609027 2021. Whole-genome Sequencing of SARS-CoV-2: Using Phylogeny and Structural Modeling to Contextualize Local Viral Evolution.
33709674 2021. Can natural immunity partially replace vaccine against SARS-COV2 infection? A small single center study.
33705368 2021. Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.
33705367 2021. First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021.
33630825 2021. First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota - December 2020-January 2021.
33630820 2021. Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020.
33605421 2021. Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2.
33555346 2021. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
33674876 2021. Identifying primate ACE2 variants that confer resistance to SARS-CoV-2.
33713597 2021. The SARS-CoV-2 subgenome landscape and its novel regulatory features.
33564990 2021. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.
33745077 2021. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.
33740184 2021. Possible role of purinergic signaling in COVID-19.
33781838 2021. Emerging importance of ACE2 in external stratified epithelial tissues.
33743061 2021. Host-dependent molecular factors mediating SARS-CoV-2 infection to gain clinical insights for developing effective targeted therapy.
33590968 2021. SARS-CoV-2 infection remodels the host protein thermal stability landscape.
33578036 2021. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
33686311 2021. PIMS - eine neue padiatrische Herausforderung: 9-Jahre alter Knabe mit SARS-CoV-2 assoziiertem hyperinflammatorischem Schocksyndrom.
33816662 2021. Severe Acute Respiratory Syndrome Coronavirus 2, Olfactory Mucosa, and the Entrance in the Central Nervous System: Expanding the Evidence?
33619443 2021. Supervised machine learning approach to molecular dynamics forecast of SARS-CoV-2 spike glycoproteins at varying temperatures.
33789940 2021. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
33692194 2021. Original Antigenic Sin: the Downside of Immunological Memory and Implications for COVID-19.
33627511 2021. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
33597174 2021. Why Are Viruses Spiked?
33568452 2021. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
33622851 2021. Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.
33608656 2021. COVID-19-from mucosal immunology to IBD patients.
33526920 2021. Myeloid-derived suppressor cells in the era of incre<iframe src="http://www.kidney.de/amapp.php?a=g myeloid cell diversity.
33723416 2021. The first 12 months of COVID-19: a timeline of immunological insights.
33753932 2021. Transmissibility and transmission of respiratory viruses.
33758362 2021. Soluble ACE2 in SARS-CoV-2 infection.
33762726 2021. Neuroimmune interactions and COVID-19 in lung transplant recipients.
33762725 2021. Reply to: Neuroimmune interactions and COVID-19 in lung transplant recipients.
33547426 2021. Immune cartography of macrophage activation syndrome in the COVID-19 era.
33609131 2021. The humoral immune response to SARS-CoV-2 mounts and is durable in symptomatic haemodialysis patients.
33720379 2021. Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19.
33680474 2021. Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an in silico analysis.
33540664 2021. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells.
33670580 2021. MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2.
33545540 2021. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?
33569904 2021. Amino acid sensing pathway: A major check point in the pathogenesis of obesity and COVID-19.
33543899 2021. Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity.
33542096 2021. Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy.
33768966 2021. Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key.
33778091 2021. Cutaneous Findings in SARS-CoV-2-Associated Multisystem Inflammatory Disease in Children.
33778090 2021. Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness.
33614814 2021. SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response.
33604403 2021. Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers.
33527081 2020. Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics.
33659153 2021. Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020.
33738456 2021. The role of pseudotype neutralization assays in understanding SARS CoV-2.
33585820 2021. Mucosal immune responses in COVID19 - a living review.
33575657 2021. T cell phenotypes in COVID-19 - a living review.
33815663 2021. HIF-1, the Warburg Effect, and Macrophage/Microglia Polarization Potential Role in COVID-19 Pathogenesis.
33691013 2021. Protein sequence models for prediction and comparative analysis of the SARS-CoV-2 -human interactome.
33631039 2021. Postoperative inflammation to "hyper"-inflammation: cryptic COVID-19 connections!
33654512 2020. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.
33706759 2021. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
33572190 2021. Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging.
33561763 2021. Fibroblast function in COVID-19.
33676105 2021. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature.
33817672 2021. Network-based virus-host interaction prediction with application to SARS-CoV-2.
33661546 2021. SARS-CoV-2-related multisystem inflammatory syndrome in an immunocompromised child with leukemia.
33547936 2021. Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies.
33551363 2021. Critical illness-associated brain microhemorrhages in a child with multisystem inflammatory syndrome secondary to coronavirus disease 2019.
33595703 2021. Imaging in support of the clinical diagnoses of COVID-19 and multisystem inflammatory syndrome in children.
33534852 2021. Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans.
33529260 2021. Clinical and whole genome characterization of SARS-CoV-2 in India.
33428634 2021. Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.